We are international
Donate

August 2011 Archives : Discussions About IMF Web Site Content

Future Perspectives/Closing Ceremony

By IMF Admin on August 31, 2011 10:25 PM | No Comments
Future Perspectives/Closing Ceremony

We Mourn the Passing of IMF Board Member, Rich Saletan

By IMF Admin on August 31, 2011 10:23 PM | No Comments
We Mourn the Passing of IMF Board Member, Rich Saletan

IL21 Induces Myeloma Cell Growth via IGF1 Autocrine Loop

By IMF Admin on August 31, 2011 7:35 PM | No Comments
IL21 Induces Myeloma Cell Growth via IGF1 Autocrine Loop

New Agents and New Opportunities for Multiple Myeloma Today and Tomorrow

By IMF Admin on August 31, 2011 5:27 PM | No Comments
New Agents and New Opportunities for Multiple Myeloma Today and Tomorrow

testing create

By IMF Admin on August 31, 2011 3:41 PM | No Comments
testing create

What's New In Research - December 3, 2002

By IMF Admin on August 31, 2011 3:24 PM | No Comments
What's New In Research - December 3, 2002

PAD COMBINATION THERAPY FOR PREVIOUSLY UNTREATED PATIENTS

By IMF Admin on August 31, 2011 1:04 PM | No Comments
PAD COMBINATION THERAPY FOR PREVIOUSLY UNTREATED PATIENTS

Extended follow-up results of BiRD therapy: prolonged responses achieved

By IMF Admin on August 31, 2011 12:50 PM | No Comments
Extended follow-up results of BiRD therapy: prolonged responses achieved

A Guide to Creative Giving

By IMF Admin on August 31, 2011 12:49 PM | No Comments
A Guide to Creative Giving

Letters To The Editor

By IMF Admin on August 31, 2011 12:48 PM | No Comments
Letters To The Editor

Third Annual Myeloma Days in Istanbul Draws Over 100 Attendees

By IMF Admin on August 31, 2011 11:05 AM | No Comments
Third Annual Myeloma Days in Istanbul Draws Over 100 Attendees

June 25, 2002: IMF Myeloma Minute

By IMF Admin on August 31, 2011 10:20 AM | No Comments
June 25, 2002: IMF Myeloma Minute

Phase IV THALOMID® Clinical Trials

By IMF Admin on August 31, 2011 9:14 AM | No Comments
Phase IV THALOMID® Clinical Trials

Myeloma Minute - May 21, 2004

By IMF Admin on August 31, 2011 8:24 AM | No Comments
Myeloma Minute - May 21, 2004

Past Professional Meetings

By IMF Admin on August 31, 2011 8:22 AM | No Comments
Past Professional Meetings

Myeloma Minute - October 9, 2004

By IMF Admin on August 31, 2011 7:51 AM | No Comments
Myeloma Minute - October 9, 2004

Greetings from Australia

By IMF Admin on August 31, 2011 7:19 AM | No Comments
Greetings from Australia

IMF ????? ????? ?????? ?? ????? ? - Revlimid

By IMF Admin on August 31, 2011 6:23 AM | No Comments
IMF ????? ????? ?????? ?? ????? ? - Revlimid

IMF ????? ????? ?????? ?? ????? ? - Revlimid

By IMF Admin on August 31, 2011 6:23 AM | No Comments
IMF ????? ????? ?????? ?? ????? ? - Revlimid

Myeloma Quilt of Courage #5 - By Debbie Tidwell

By IMF Admin on August 31, 2011 5:03 AM | No Comments
Myeloma Quilt of Courage #5 - By Debbie Tidwell

IMF OFFICE HOLIDAY HOURS

By IMF Admin on August 31, 2011 5:01 AM | No Comments
IMF OFFICE HOLIDAY HOURS

Edmundo Gorga

By IMF Admin on August 31, 2011 4:26 AM | No Comments
Edmundo Gorga

An IMF tip-sheet: How to Round Out Your Trip to the IMF's 16th Anniversary Gala

By IMF Admin on August 31, 2011 4:13 AM | No Comments
An IMF tip-sheet: How to Round Out Your Trip to the IMF's 16th Anniversary Gala

RUN THE NYC MARATHON AND FIGHT MYELOMA

By IMF Admin on August 31, 2011 4:09 AM | No Comments
RUN THE NYC MARATHON AND FIGHT MYELOMA

,IMF????? ?? ????? ?? ??????? ????? ?"? ????? ??"?, ??????? ???????? ? ????? ???? ????? ??????? ?????? 3/6/2011 ????? ????? ???????. ????? ?? ???? ?? ??????? ?? ????? ??"?

By IMF Admin on August 31, 2011 4:04 AM | No Comments
,IMF????? ?? ????? ?? ??????? ????? ?"? ????? ??"?, ??????? ???????? ? ????? ???? ????? ??????? ?????? 3/6/2011 ????? ????? ???????. ????? ?? ???? ?? ??????? ?? ????? ??"?

Proteomic analysis of Multiple Myeloma identifies upregulation of the novel protein CRIK

By IMF Admin on August 31, 2011 3:44 AM | No Comments
Proteomic analysis of Multiple Myeloma identifies upregulation of the novel protein CRIK

Myeloma Quilt of Courage #2 - David Michael Hahn

By IMF Admin on August 31, 2011 3:35 AM | No Comments
Myeloma Quilt of Courage #2 - David Michael Hahn

COMING SOON! MyrooM! Home of the IMF blogs.

By IMF Admin on August 31, 2011 3:33 AM | No Comments
COMING SOON! MyrooM! Home of the IMF blogs.

KOS 2007: The Role of Donor-Lymphocyte Infusion and Other Post-Transplant Strategies After Allografting in Multiple Myeloma

By IMF Admin on August 31, 2011 1:11 AM | No Comments
KOS 2007: The Role of Donor-Lymphocyte Infusion and Other Post-Transplant Strategies After Allografting in Multiple Myeloma

Opening of National Oncologic PET Registery Hits Snag.

By IMF Admin on August 31, 2011 12:57 AM | No Comments
Opening of National Oncologic PET Registery Hits Snag.

Past Meetings

By IMF Admin on August 31, 2011 12:09 AM | No Comments
Past Meetings

January 20, 2004 Myeloma Minute

By IMF Admin on August 30, 2011 9:44 PM | No Comments
January 20, 2004 Myeloma Minute

John Peter Thompson

By IMF Admin on August 30, 2011 9:32 PM | No Comments
John Peter Thompson

STEP 5 - TRANSPLANT REFERENCES

By IMF Admin on August 30, 2011 9:03 PM | No Comments
STEP 5 - TRANSPLANT REFERENCES

Congressional Conferees Move Closer to Medicare Agreement

By IMF Admin on August 30, 2011 8:31 PM | No Comments
Congressional Conferees Move Closer to Medicare Agreement

Myeloma Quilt of Courage # 5 - By Karen Maru

By IMF Admin on August 30, 2011 7:48 PM | No Comments
Myeloma Quilt of Courage # 5 - By Karen Maru

THE INTERNATIONAL MYELOMA FOUNDATION ANNOUNCES BREAKTHROUGH AGREEMENT WITH CHINA TO SUPPORT MYELOMA TREATMENT, INFORMATION AND RESEARCH

By IMF Admin on August 30, 2011 7:17 PM | No Comments
THE INTERNATIONAL MYELOMA FOUNDATION ANNOUNCES BREAKTHROUGH AGREEMENT WITH CHINA TO SUPPORT MYELOMA TREATMENT, INFORMATION AND RESEARCH

Celebrating a Life: IMFer Gerry Difford

By IMF Admin on August 30, 2011 6:48 PM | No Comments
Celebrating a Life: IMFer Gerry Difford

Dr. Richardson - ASH 2008 -

By IMF Admin on August 30, 2011 6:32 PM | No Comments
Dr. Richardson - ASH 2008 -

Myeloma Quilt of Courage #3 - Barbara Jewell

By IMF Admin on August 30, 2011 6:09 PM | No Comments
Myeloma Quilt of Courage #3 - Barbara Jewell

IMF Myeloma Minute: March 12, 2002

By IMF Admin on August 30, 2011 6:07 PM | No Comments
IMF Myeloma Minute: March 12, 2002

August 6, 2002 IMF Myeloma Minute

By IMF Admin on August 30, 2011 6:05 PM | No Comments
August 6, 2002 IMF Myeloma Minute

Professor Jean-Luc Harousseau Receives Prestigious Waldenstrom Award for a Lifetime of Achievement

By IMF Admin on August 30, 2011 4:34 PM | No Comments
Professor Jean-Luc Harousseau Receives Prestigious Waldenstrom Award for a Lifetime of Achievement

YOUR IMF DOLLARS AT WORK

By IMF Admin on August 30, 2011 4:05 PM | No Comments
YOUR IMF DOLLARS AT WORK

Report from the Hope & Trust Meeting at the Royal College of Physicians

By IMF Admin on August 30, 2011 3:51 PM | No Comments
Report from the Hope & Trust Meeting at the Royal College of Physicians

March 6, 2003 Myeloma Minute

By IMF Admin on August 30, 2011 3:39 PM | No Comments
March 6, 2003 Myeloma Minute

What's New In Research - April 4, 2003

By IMF Admin on August 30, 2011 3:30 PM | No Comments
What's New In Research - April 4, 2003

Sydney 2005:
Bone Marrow Homing of MM Cell

By IMF Admin on August 30, 2011 3:23 PM | No Comments
Sydney 2005:
Bone Marrow Homing of MM Cell

Sydney 2005:
Drug Resistance in Multiple Myeloma

By IMF Admin on August 30, 2011 3:21 PM | No Comments
Sydney 2005:
Drug Resistance in Multiple Myeloma

October 22, 2002 IMF Myeloma Minute

By IMF Admin on August 30, 2011 2:59 PM | No Comments
October 22, 2002 IMF Myeloma Minute

October 22, 2002 IMF Myeloma Minute

By IMF Admin on August 30, 2011 2:59 PM | No Comments
October 22, 2002 IMF Myeloma Minute

MEDIA ALERT - MINNEAPOLIS PATIENT & FAMILY SEMINAR

By IMF Admin on August 30, 2011 2:34 PM | No Comments
MEDIA ALERT - MINNEAPOLIS PATIENT & FAMILY SEMINAR

What's New In Research - September 21, 2003

By IMF Admin on August 30, 2011 11:07 AM | No Comments
What's New In Research - September 21, 2003

G.S. Viswanathan

By IMF Admin on August 30, 2011 9:35 AM | No Comments
G.S. Viswanathan

MicroRNA expression profiling in multiple myeloma: correlation with genetic abnormalities

By IMF Admin on August 30, 2011 8:43 AM | No Comments
MicroRNA expression profiling in multiple myeloma: correlation with genetic abnormalities

The Role Of The Ras Oncogene In Multiple Myeloma Spread

By IMF Admin on August 30, 2011 8:24 AM | No Comments
The Role Of The Ras Oncogene In Multiple Myeloma Spread

Dr. Durie featured in BioWorld® Today article With Advances in Genomics, Exosomes Broaden Horizons

By IMF Admin on August 30, 2011 7:57 AM | No Comments
Dr. Durie featured in BioWorld® Today article With Advances in Genomics, Exosomes Broaden Horizons

Report from Tokyo 2004 Patient and Family Seminar

By IMF Admin on August 30, 2011 7:15 AM | No Comments
Report from Tokyo 2004 Patient and Family Seminar

IMF Holds First MM Interactive Patient/Family Seminar In Seattle

By IMF Admin on August 30, 2011 6:02 AM | No Comments
IMF Holds First MM Interactive Patient/Family Seminar In Seattle

Isolation Of Myeloma-Cytotoxic T Lymphocytes - Identification of Myeloma Tumor Antigents

By IMF Admin on August 30, 2011 6:00 AM | No Comments
Isolation Of Myeloma-Cytotoxic T Lymphocytes - Identification of Myeloma Tumor Antigents

February 13, 2004 Myeloma Minute

By IMF Admin on August 30, 2011 5:03 AM | No Comments
February 13, 2004 Myeloma Minute

Afternoon Tea in Washington DC

By IMF Admin on August 30, 2011 4:43 AM | No Comments
Afternoon Tea in Washington DC

INTERNATIONAL MYELOMA FOUNDATION OVERWHELMED AS CELEBRITY MICHAEL McKEAN WINS $1 MILLION GRAND PRIZE ON 'JEOPARDY!' MILLION DOLLAR CELEBRITY INVITATIONAL

By IMF Admin on August 30, 2011 4:19 AM | No Comments
INTERNATIONAL MYELOMA FOUNDATION OVERWHELMED AS CELEBRITY MICHAEL McKEAN WINS $1 MILLION GRAND PRIZE ON 'JEOPARDY!' MILLION DOLLAR CELEBRITY INVITATIONAL

Bank On A Cure

By IMF Admin on August 30, 2011 4:18 AM | No Comments
Bank On A Cure

Medicare eligible? Apply NOW to save 90% of thalidomide costs!

By IMF Admin on August 30, 2011 2:15 AM | No Comments
Medicare eligible? Apply NOW to save 90% of thalidomide costs!

Myeloma Quilt of Courage #3 - Judy Van Schoyck

By IMF Admin on August 30, 2011 1:50 AM | No Comments
Myeloma Quilt of Courage #3 - Judy Van Schoyck

Single-agent bortezomib in previously untreated MM:
Results of a phase II multicenter study.

By IMF Admin on August 30, 2011 1:44 AM | No Comments
Single-agent bortezomib in previously untreated MM:
Results of a phase II multicenter study.

Dose-escalating & pharmacologic study of bortezomib in adult cancer pts with impaired renal function

By IMF Admin on August 30, 2011 1:42 AM | No Comments
Dose-escalating & pharmacologic study of bortezomib in adult cancer pts with impaired renal function

Requesting your help with a Bone Health Survey for Myeloma Patients and Caregivers

By IMF Admin on August 30, 2011 1:13 AM | No Comments
Requesting your help with a Bone Health Survey for Myeloma Patients and Caregivers

Post-ASCT Thalidomide Consolidation Further Prolongs PFS For Patients That Have Already Achieved A Complete or Very Good Partial Response

By IMF Admin on August 30, 2011 12:21 AM | No Comments
Post-ASCT Thalidomide Consolidation Further Prolongs PFS For Patients That Have Already Achieved A Complete or Very Good Partial Response

More than 50 scientists were interviewed at this year's meeting of the American Society of Hematology (ASH)

By IMF Admin on August 29, 2011 11:36 PM | No Comments
More than 50 scientists were interviewed at this year's meeting of the American Society of Hematology (ASH)

Fiesta for a Cure! - Prizes

By IMF Admin on August 29, 2011 11:34 PM | No Comments
Fiesta for a Cure! - Prizes

Katie's Birthday
The Touching Story of a Little Girl's Love

By IMF Admin on August 29, 2011 11:13 PM | No Comments
Katie's Birthday
The Touching Story of a Little Girl's Love

Information in German About Multiple Myeloma

By IMF Admin on August 29, 2011 11:12 PM | No Comments
Information in German About Multiple Myeloma

Congress Moves to Finish Old Business

By IMF Admin on August 29, 2011 9:43 PM | No Comments
Congress Moves to Finish Old Business

July 9, 2002: IMF Myeloma Minute

By IMF Admin on August 29, 2011 9:39 PM | No Comments
July 9, 2002: IMF Myeloma Minute

Anonymous #2

By IMF Admin on August 29, 2011 9:27 PM | No Comments
Anonymous #2

Myeloma Minute: Important News from Washington

By IMF Admin on August 29, 2011 7:04 PM | No Comments
Myeloma Minute: Important News from Washington

PRESS OFFICE

By IMF Admin on August 29, 2011 7:04 PM | No Comments
PRESS OFFICE

The Black Swan Approach, or Cure = MC5
By Brian G.M. Durie, MD

By IMF Admin on August 29, 2011 7:03 PM | No Comments
The Black Swan Approach, or Cure = MC5
By Brian G.M. Durie, MD

Privacy Policy

By IMF Admin on August 29, 2011 7:03 PM | No Comments
Privacy Policy

aCGH in Vk*MYC mice identifies genetic changes shared with human MM

By IMF Admin on August 29, 2011 7:02 PM | No Comments
aCGH in Vk*MYC mice identifies genetic changes shared with human MM

Sydney 2005:
State of the Art of Allogenic Transplantation in MM

By IMF Admin on August 29, 2011 6:14 PM | No Comments
Sydney 2005:
State of the Art of Allogenic Transplantation in MM

ASCO 2006 INDUSTRY NEWS

By IMF Admin on August 29, 2011 5:31 PM | No Comments
ASCO 2006 INDUSTRY NEWS

April 9, 2002: IMF Myeloma Minute

By IMF Admin on August 29, 2011 5:03 PM | No Comments
April 9, 2002: IMF Myeloma Minute

Frank Meyers

By IMF Admin on August 29, 2011 4:05 PM | No Comments
Frank Meyers

What is One Voice Against Cancer?

By IMF Admin on August 29, 2011 3:31 PM | No Comments
What is One Voice Against Cancer?

Report from the Kyoto Seminar 2005

By IMF Admin on August 29, 2011 3:10 PM | No Comments
Report from the Kyoto Seminar 2005

Ministry Recap and Reflection - July 2005

By IMF Admin on August 29, 2011 11:28 AM | No Comments
Ministry Recap and Reflection - July 2005

Phase II VELCADE® Clinical Trials

By IMF Admin on August 29, 2011 11:18 AM | No Comments
Phase II VELCADE® Clinical Trials

Bill Miller

By IMF Admin on August 29, 2011 11:14 AM | No Comments
Bill Miller

Myeloma Quilt of Courage #3 - Leslie Cohen

By IMF Admin on August 29, 2011 11:12 AM | No Comments
Myeloma Quilt of Courage #3 - Leslie Cohen

Myeloma Quilt of Courage #1 - Judith Copple

By IMF Admin on August 29, 2011 4:05 AM | No Comments
Myeloma Quilt of Courage #1 - Judith Copple

Myeloma Quilt of Courage #1 - Amy Brown

By IMF Admin on August 29, 2011 4:04 AM | No Comments
Myeloma Quilt of Courage #1 - Amy Brown

Myeloma Quilt of Courage #1 - Susan Buzzell

By IMF Admin on August 28, 2011 10:45 PM | No Comments
Myeloma Quilt of Courage #1 - Susan Buzzell

Giuseppe Avvisati, MD

By IMF Admin on August 28, 2011 10:37 PM | No Comments
Giuseppe Avvisati, MD

Sydney 2005: In MM Cells, Birn Pro-Apoptotic Functionis Neutralized Thru Endogenous Mcl-1/Birn ...

By IMF Admin on August 28, 2011 10:37 PM | No Comments
Sydney 2005: In MM Cells, Birn Pro-Apoptotic Functionis Neutralized Thru Endogenous Mcl-1/Birn ...

Update on Multicenter Atiprimod Trial

By IMF Admin on August 28, 2011 9:20 PM | No Comments
Update on Multicenter Atiprimod Trial

Documentary Film Company Searching for Myeloma Patients Who Are Taking Thalidomide

By IMF Admin on August 28, 2011 8:09 PM | No Comments
Documentary Film Company Searching for Myeloma Patients Who Are Taking Thalidomide

Myeloma Quilt of Courage #4 - To My Dad

By IMF Admin on August 28, 2011 8:06 PM | No Comments
Myeloma Quilt of Courage #4 - To My Dad

What's New in Research - November 19, 2002

By IMF Admin on August 28, 2011 7:30 PM | No Comments
What's New in Research - November 19, 2002

Myeloma Quilt of Courage #4 - Frankie Salgado

By IMF Admin on August 28, 2011 7:06 PM | No Comments
Myeloma Quilt of Courage #4 - Frankie Salgado

11/9/01 Myeloma Minute

By IMF Admin on August 28, 2011 6:06 PM | No Comments
11/9/01 Myeloma Minute

Myeloma Quilt of Courage #2 - Eva Mathisen

By IMF Admin on August 28, 2011 6:06 PM | No Comments
Myeloma Quilt of Courage #2 - Eva Mathisen

October 15, 2002 IMF Myeloma Minute

By IMF Admin on August 28, 2011 4:56 PM | No Comments
October 15, 2002 IMF Myeloma Minute

What's New in Research - October 22, 2002

By IMF Admin on August 28, 2011 1:37 PM | No Comments
What's New in Research - October 22, 2002

Sydney 2005:
Bcl-xl, Myc, and Mutant Ras Transgenic Mouse Models of Plasma Cell Malignancies

By IMF Admin on August 28, 2011 12:55 PM | No Comments
Sydney 2005:
Bcl-xl, Myc, and Mutant Ras Transgenic Mouse Models of Plasma Cell Malignancies

Planning Treatment

By IMF Admin on August 28, 2011 10:51 AM | No Comments
Planning Treatment

Myeloma Quilt of Courage #2 - Millie Harris

By IMF Admin on August 28, 2011 9:06 AM | No Comments
Myeloma Quilt of Courage #2 - Millie Harris

Mozobil Tip Card

By IMF Admin on August 28, 2011 9:06 AM | No Comments
Mozobil Tip Card

July 30, 2002 IMF Myeloma Minute

By IMF Admin on August 28, 2011 9:03 AM | No Comments
July 30, 2002 IMF Myeloma Minute

International Myeloma Foundation Heralds ECOG Announcement

By IMF Admin on August 28, 2011 8:40 AM | No Comments
International Myeloma Foundation Heralds ECOG Announcement

PREGUNTAS PARA HACERLE A SU DOCTOR

By IMF Admin on August 28, 2011 8:08 AM | No Comments
PREGUNTAS PARA HACERLE A SU DOCTOR

Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)

By IMF Admin on August 28, 2011 7:39 AM | No Comments
Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003)

Myeloma Quilt of Courage #2 - Forever, Always and Beyond

By IMF Admin on August 28, 2011 7:17 AM | No Comments
Myeloma Quilt of Courage #2 - Forever, Always and Beyond

Myeloma Expert Dr. Phil Greipp to Run in Olympic Torch Relay

By IMF Admin on August 28, 2011 7:16 AM | No Comments
Myeloma Expert Dr. Phil Greipp to Run in Olympic Torch Relay

June Pruitt

By IMF Admin on August 28, 2011 7:05 AM | No Comments
June Pruitt

Dr. Jagannath - ASH 2008 - Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma

By IMF Admin on August 28, 2011 6:52 AM | No Comments
Dr. Jagannath - ASH 2008 - Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma

MYELOMA MINUTE SPECIAL EDITION - REPORT FROM ASCO 2004

By IMF Admin on August 28, 2011 6:40 AM | No Comments
MYELOMA MINUTE SPECIAL EDITION - REPORT FROM ASCO 2004

OVAC 2002: IMF Participates In One Voice Against Cancer Advocacy Day

By IMF Admin on August 28, 2011 6:38 AM | No Comments
OVAC 2002: IMF Participates In One Voice Against Cancer Advocacy Day

Myeloma Minute - August 18, 2004

By IMF Admin on August 28, 2011 6:09 AM | No Comments
Myeloma Minute - August 18, 2004

The IMF Presents the 2nd Annual Myeloma Awareness Week

By IMF Admin on August 28, 2011 6:08 AM | No Comments
The IMF Presents the 2nd Annual Myeloma Awareness Week

Out and About in Beverly Hills

By IMF Admin on August 28, 2011 6:08 AM | No Comments
Out and About in Beverly Hills

Sydney 2005:
Smoldering MM: Criteria for Diagnosis & Results of Long-Term Follow-Up

By IMF Admin on August 28, 2011 5:49 AM | No Comments
Sydney 2005:
Smoldering MM: Criteria for Diagnosis & Results of Long-Term Follow-Up

Sydney 2005:
Pathogenesis of Myeloma: Ig Translocations, Cyclin D Dysregulation, Other Events

By IMF Admin on August 28, 2011 5:46 AM | No Comments
Sydney 2005:
Pathogenesis of Myeloma: Ig Translocations, Cyclin D Dysregulation, Other Events

Sydney 2005:
Clinical and Biologic Implications of Genomics in Myeloma

By IMF Admin on August 28, 2011 5:18 AM | No Comments
Sydney 2005:
Clinical and Biologic Implications of Genomics in Myeloma

Efficacy and Safety of anti-b2M mAbs to Treat MM

By IMF Admin on August 28, 2011 4:42 AM | No Comments
Efficacy and Safety of anti-b2M mAbs to Treat MM

Molecular Mechanisms Of Myeloma Cell Resistance To Apoptosis

By IMF Admin on August 28, 2011 4:38 AM | No Comments
Molecular Mechanisms Of Myeloma Cell Resistance To Apoptosis

Sydney 2005:
Unconventional Switched Bone Marrow Plasma Cells with Ig V-region Mutations

By IMF Admin on August 28, 2011 4:24 AM | No Comments
Sydney 2005:
Unconventional Switched Bone Marrow Plasma Cells with Ig V-region Mutations

The IMF mourns the loss of Dr. Gregory Mundy, member of IMF Board of Scientific Advisors and Board of Directors.

By IMF Admin on August 28, 2011 4:21 AM | No Comments
The IMF mourns the loss of Dr. Gregory Mundy, member of IMF Board of Scientific Advisors and Board of Directors.

The new site

By IMF Admin on August 28, 2011 4:08 AM | No Comments
The new site

Robert Heeren

By IMF Admin on August 28, 2011 3:58 AM | No Comments
Robert Heeren

Daniel Stephenson

By IMF Admin on August 28, 2011 3:56 AM | No Comments
Daniel Stephenson

Torino Myeloma Conference
April 22, 2004

By IMF Admin on August 28, 2011 3:00 AM | No Comments
Torino Myeloma Conference
April 22, 2004

Dorothy Russell

By IMF Admin on August 28, 2011 2:53 AM | No Comments
Dorothy Russell

House Leadership Uses Obscure Procedural Move to Cap Spending Levels

By IMF Admin on August 28, 2011 2:47 AM | No Comments
House Leadership Uses Obscure Procedural Move to Cap Spending Levels

Rosanne Kalick

By IMF Admin on August 28, 2011 1:47 AM | No Comments
Rosanne Kalick

DEVELOPMENT, PREDICTION, AND TREATMENT OF ANEMIA IN PATIENTS WITH LYMPHOMA/MM

By IMF Admin on August 28, 2011 1:31 AM | No Comments
DEVELOPMENT, PREDICTION, AND TREATMENT OF ANEMIA IN PATIENTS WITH LYMPHOMA/MM

CMS May Limit Off-Label Coverage For Cancer Drugs To Clinical Trials

By IMF Admin on August 28, 2011 1:20 AM | No Comments
CMS May Limit Off-Label Coverage For Cancer Drugs To Clinical Trials

Myeloma Quilt of Courage #2 - Al Fitzgerald

By IMF Admin on August 28, 2011 1:20 AM | No Comments
Myeloma Quilt of Courage #2 - Al Fitzgerald

January 8, 2003 Myeloma Minute

By IMF Admin on August 28, 2011 1:18 AM | No Comments
January 8, 2003 Myeloma Minute

2nd Annual Cancer Survivorship Telephone Education Workshop Series, Cancer Survivorship

By IMF Admin on August 28, 2011 1:13 AM | No Comments
2nd Annual Cancer Survivorship Telephone Education Workshop Series, Cancer Survivorship

Myeloma Minute - August 2, 2004

By IMF Admin on August 28, 2011 12:19 AM | No Comments
Myeloma Minute - August 2, 2004

14th Anniversary Ribbon of Hope Gala Honorees:
RIBBON OF HOPE AWARD

By IMF Admin on August 28, 2011 12:12 AM | No Comments
14th Anniversary Ribbon of Hope Gala Honorees:
RIBBON OF HOPE AWARD

April 2, 2002: IMF Myeloma Minute

By IMF Admin on August 27, 2011 11:57 PM | No Comments
April 2, 2002: IMF Myeloma Minute

Characterization of 14q32 Translocations In Multiple Myeloma

By IMF Admin on August 27, 2011 11:51 PM | No Comments
Characterization of 14q32 Translocations In Multiple Myeloma

Torino Myeloma Conference
April 24, 2004

By IMF Admin on August 27, 2011 11:48 PM | No Comments
Torino Myeloma Conference
April 24, 2004

Advocacy Update - August 3, 2009

By IMF Admin on August 27, 2011 11:46 PM | No Comments
Advocacy Update - August 3, 2009

Ellen Palmer

By IMF Admin on August 27, 2011 11:22 PM | No Comments
Ellen Palmer

Philip Scheble

By IMF Admin on August 27, 2011 10:34 PM | No Comments
Philip Scheble

Dr. Wijermans - ASH 2008 - Overview of ASH 2008 in Dutch

By IMF Admin on August 27, 2011 10:21 PM | No Comments
Dr. Wijermans - ASH 2008 - Overview of ASH 2008 in Dutch

The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma ? An Update

By IMF Admin on August 27, 2011 9:59 PM | No Comments
The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma ? An Update

House Leadership Presses for Budget Bill Opposed by Health Advocates

By IMF Admin on August 27, 2011 9:30 PM | No Comments
House Leadership Presses for Budget Bill Opposed by Health Advocates

VELCADE® (bortezomib) for Injection

By IMF Admin on August 27, 2011 9:17 PM | No Comments
VELCADE® (bortezomib) for Injection

Myeloma Quilt of Courage #4 - Calvin Lamont Tidwell

By IMF Admin on August 27, 2011 9:15 PM | No Comments
Myeloma Quilt of Courage #4 - Calvin Lamont Tidwell

Valerie Holloway

By IMF Admin on August 27, 2011 8:54 PM | No Comments
Valerie Holloway

Marla Barnett

By IMF Admin on August 27, 2011 8:45 PM | 1 Comment
Marla Barnett

Myeloma Quilt of Courage #5 - In Memory of Tim Woomer

By IMF Admin on August 27, 2011 8:40 PM | No Comments
Myeloma Quilt of Courage #5 - In Memory of Tim Woomer

Guia Para el Paciente 2003 - T

By IMF Admin on August 27, 2011 8:27 PM | No Comments
Guia Para el Paciente 2003 - T

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Panel Discussion II

By IMF Admin on August 27, 2011 8:23 PM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Panel Discussion II

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Mellqvist - Improved progression free survival with bortezomib consolidation after high dose melphalan; results of a randomized phase III trial

By IMF Admin on August 27, 2011 8:21 PM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Mellqvist - Improved progression free survival with bortezomib consolidation after high dose melphalan; results of a randomized phase III trial

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Panel Discussion I

By IMF Admin on August 27, 2011 8:19 PM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Panel Discussion I

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Cavallo - A Phase III Study of Enoxaparin vs Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-based Regimens

By IMF Admin on August 27, 2011 8:17 PM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Cavallo - A Phase III Study of Enoxaparin vs Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide-based Regimens

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Futreal - INTRODUCTION LECTURE: Initial genome sequencing: a new step in understanding Myeloma?

By IMF Admin on August 27, 2011 8:15 PM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Futreal - INTRODUCTION LECTURE: Initial genome sequencing: a new step in understanding Myeloma?

International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 1
Dr. Ludwig - Consensus guidelines for the management of anemia with erythropoiesis stimulating agents (ESAs) in multiple myeloma

By IMF Admin on August 27, 2011 8:08 PM | No Comments
International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 1
Dr. Ludwig - Consensus guidelines for the management of anemia with erythropoiesis stimulating agents (ESAs) in multiple myeloma

test richie

By IMF Admin on August 27, 2011 8:07 PM | No Comments
test richie

International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Panel Discussion

By IMF Admin on August 27, 2011 8:03 PM | No Comments
International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Panel Discussion

International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Chauhan - Preclinical Basis for 2nd Generation Proteasome Inhibitors
Presented by Dr. Kenneth Anderson

By IMF Admin on August 27, 2011 7:58 PM | No Comments
International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Chauhan - Preclinical Basis for 2nd Generation Proteasome Inhibitors
Presented by Dr. Kenneth Anderson

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Straka - Report from EMNTG-DSMM

By IMF Admin on August 27, 2011 7:51 PM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Straka - Report from EMNTG-DSMM

International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Pepys - Introduction lecture: "Therapeutic elimination of amyloid deposits: is it possible?"

By IMF Admin on August 27, 2011 7:44 PM | No Comments
International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Pepys - Introduction lecture: "Therapeutic elimination of amyloid deposits: is it possible?"

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Terpos - Should we use markers of bone remodelling in Myeloma? Which one and when?

By IMF Admin on August 27, 2011 7:42 PM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Terpos - Should we use markers of bone remodelling in Myeloma? Which one and when?

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Child - Zoledronic Acid in the Management of Myeloma

By IMF Admin on August 27, 2011 7:40 PM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Child - Zoledronic Acid in the Management of Myeloma

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Gimsing - Bisphosphonates: Can the Dose be Lowered?

By IMF Admin on August 27, 2011 7:39 PM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Gimsing - Bisphosphonates: Can the Dose be Lowered?

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Hillengass - Whole-body MRI in Myeloma

By IMF Admin on August 27, 2011 7:38 PM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Hillengass - Whole-body MRI in Myeloma

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Dimopoulos - Introduction lecture: "Bone imaging in Myeloma: old scaffolds and new avenues"

By IMF Admin on August 27, 2011 7:37 PM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Dimopoulos - Introduction lecture: "Bone imaging in Myeloma: old scaffolds and new avenues"

International Myeloma Workshop 2011
DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM?
Dr. Lonial - Against Treatment

By IMF Admin on August 27, 2011 7:36 PM | No Comments
International Myeloma Workshop 2011
DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM?
Dr. Lonial - Against Treatment

International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Panel Discussion

By IMF Admin on August 27, 2011 7:27 PM | No Comments
International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Panel Discussion

International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Barlogie - Report from Arkansas

By IMF Admin on August 27, 2011 7:24 PM | No Comments
International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Barlogie - Report from Arkansas

International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Panel discussion

By IMF Admin on August 27, 2011 7:13 PM | No Comments
International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Panel discussion

International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Klein - Cytokine Pathways: Which One to Target?

By IMF Admin on August 27, 2011 7:11 PM | No Comments
International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Klein - Cytokine Pathways: Which One to Target?

Sept. 1, 1999 -- VII International Workshop, Stockholm Sweden

By IMF Admin on August 27, 2011 6:14 PM | No Comments
Sept. 1, 1999 -- VII International Workshop, Stockholm Sweden

14th Anniversary Ribbon of Hope Gala Honorees:
COURAGE AWARD

By IMF Admin on August 27, 2011 6:11 PM | No Comments
14th Anniversary Ribbon of Hope Gala Honorees:
COURAGE AWARD

Skeletal Targeted Radiotherapy (STR?)

By IMF Admin on August 27, 2011 5:28 PM | No Comments
Skeletal Targeted Radiotherapy (STR?)

Thalidomide Editorial

By IMF Admin on August 27, 2011 5:08 PM | No Comments
Thalidomide Editorial

Innovative Technologies

By IMF Admin on August 27, 2011 4:49 PM | No Comments
Innovative Technologies

Kaposi's Sarcoma-Associated Herpesvirus Cytokines in the Oncogenesis of Multiple Myeloma

By IMF Admin on August 27, 2011 4:40 PM | No Comments
Kaposi's Sarcoma-Associated Herpesvirus Cytokines in the Oncogenesis of Multiple Myeloma

Targeted Radioimmunotherapy For The Treatment Of Myeloma: A Preliminary Pharmacodynamic Study

By IMF Admin on August 27, 2011 4:27 PM | No Comments
Targeted Radioimmunotherapy For The Treatment Of Myeloma: A Preliminary Pharmacodynamic Study

test dummy english article

By IMF Admin on August 27, 2011 4:14 PM | No Comments
test dummy english article

Defining the Disease

By IMF Admin on August 27, 2011 3:47 PM | No Comments
Defining the Disease

Myeloma Quilt of Courage #5 - In Memory of Rich Ramsaier

By IMF Admin on August 27, 2011 3:46 PM | No Comments
Myeloma Quilt of Courage #5 - In Memory of Rich Ramsaier

Report on the VII International Workshop on Multiple Myeloma, Stockholm, Sweden, Sept. 1-5, 1999

By IMF Admin on August 27, 2011 3:30 PM | No Comments
Report on the VII International Workshop on Multiple Myeloma, Stockholm, Sweden, Sept. 1-5, 1999

Phase I/II THALOMID® Clinical Trials

By IMF Admin on August 27, 2011 2:56 PM | No Comments
Phase I/II THALOMID® Clinical Trials

August 18, 2003 Myeloma Minute

By IMF Admin on August 27, 2011 2:34 PM | No Comments
August 18, 2003 Myeloma Minute

June, 2001 Senate Hearing on Blood Cancer Research: A personal photo journal

By IMF Admin on August 27, 2011 2:25 PM | No Comments
June, 2001 Senate Hearing on Blood Cancer Research: A personal photo journal

Download the classic folksong Shenandoah to your iPod or Zune, and make a donation to the the IMF.

By IMF Admin on August 27, 2011 2:21 PM | No Comments
Download the classic folksong Shenandoah to your iPod or Zune, and make a donation to the the IMF.

International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Leblond - Update in the Treatment of WM

By IMF Admin on August 27, 2011 1:54 PM | No Comments
International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Leblond - Update in the Treatment of WM

Myeloma Quilt of Courage #3 - Serafin Salgado

By IMF Admin on August 27, 2011 1:42 PM | No Comments
Myeloma Quilt of Courage #3 - Serafin Salgado

Myeloma Quilt of Courage #4 - Sandy

By IMF Admin on August 27, 2011 1:22 PM | No Comments
Myeloma Quilt of Courage #4 - Sandy

Senate Fails to Pass Amendment to Increase Research Funds

By IMF Admin on August 27, 2011 1:13 PM | No Comments
Senate Fails to Pass Amendment to Increase Research Funds

Sept. 2, 1999 -- VII International Workshop on Multiple Myeloma, Stockholm, Sweden

By IMF Admin on August 27, 2011 1:13 PM | No Comments
Sept. 2, 1999 -- VII International Workshop on Multiple Myeloma, Stockholm, Sweden

HOPELINK?An open, searchable database of clinical trials, customized for the IMF.

By IMF Admin on August 27, 2011 1:11 PM | No Comments
HOPELINK?An open, searchable database of clinical trials, customized for the IMF.

IMF Live Webcast From the XIIth International Myeloma Workshop

By IMF Admin on August 27, 2011 12:46 PM | No Comments
IMF Live Webcast From the XIIth International Myeloma Workshop

Signaling and Microenvironment

By IMF Admin on August 27, 2011 12:38 PM | No Comments
Signaling and Microenvironment

International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Vanderkerken - Epigenetic Changes of Myeloma Cells Within the Bone Marrow Microenvironment

By IMF Admin on August 27, 2011 12:11 PM | No Comments
International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Vanderkerken - Epigenetic Changes of Myeloma Cells Within the Bone Marrow Microenvironment

What's New In Research - December 22, 2003

By IMF Admin on August 27, 2011 12:06 PM | No Comments
What's New In Research - December 22, 2003

Daniel R. Bergsagel, MD

By IMF Admin on August 27, 2011 11:20 AM | No Comments
Daniel R. Bergsagel, MD

Myeloma Quilt of Courage #1 - Linda Wooten

By IMF Admin on August 27, 2011 11:19 AM | No Comments
Myeloma Quilt of Courage #1 - Linda Wooten

BOTTLES FOR GRANDPA

By IMF Admin on August 27, 2011 11:19 AM | No Comments
BOTTLES FOR GRANDPA

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Davies - Report from EMNTG-MRC

By IMF Admin on August 27, 2011 10:50 AM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Davies - Report from EMNTG-MRC

International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 1
Dr. Anaissie - Consensus guidelines for infection prophylaxis including vaccination

By IMF Admin on August 27, 2011 10:40 AM | No Comments
International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 1
Dr. Anaissie - Consensus guidelines for infection prophylaxis including vaccination

Myeloma Minute Special Edition- FDA Approves Velcade for Myeloma Treatment

By IMF Admin on August 27, 2011 10:23 AM | No Comments
Myeloma Minute Special Edition- FDA Approves Velcade for Myeloma Treatment

KOS 2007: Is there still a place for high-dose therapy in the elderly myeloma patients?

By IMF Admin on August 27, 2011 9:53 AM | No Comments
KOS 2007: Is there still a place for high-dose therapy in the elderly myeloma patients?

THALIDOMIDE

By IMF Admin on August 27, 2011 9:46 AM | No Comments
THALIDOMIDE

Our Guiding Light Shines Bright

By IMF Admin on August 27, 2011 9:35 AM | No Comments
Our Guiding Light Shines Bright

Sample Lost Contact Letter

By IMF Admin on August 27, 2011 9:34 AM | No Comments
Sample Lost Contact Letter

International Myeloma Workshop 2011
DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM?
Dr. Mateos - For Treatment

By IMF Admin on August 27, 2011 8:57 AM | No Comments
International Myeloma Workshop 2011
DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM?
Dr. Mateos - For Treatment

Jerry Petet

By IMF Admin on August 27, 2011 8:33 AM | No Comments
Jerry Petet

Myeloma Quilt of Courage #1 - Nancy Locrecchio

By IMF Admin on August 27, 2011 7:36 AM | No Comments
Myeloma Quilt of Courage #1 - Nancy Locrecchio

Conversations at EHA 2008
Heinz Ludwig, MD
Wilhelminen Hospital, Vienna, Austria

By IMF Admin on August 27, 2011 7:26 AM | No Comments
Conversations at EHA 2008
Heinz Ludwig, MD
Wilhelminen Hospital, Vienna, Austria

International Myeloma Workshop 2011
OPENING REMARKS

By IMF Admin on August 27, 2011 7:12 AM | No Comments
International Myeloma Workshop 2011
OPENING REMARKS

Heinz Ludwig, MD

By IMF Admin on August 27, 2011 6:19 AM | No Comments
Heinz Ludwig, MD

Myeloma Quilt of Courage #2 - Mari Payne

By IMF Admin on August 27, 2011 6:02 AM | No Comments
Myeloma Quilt of Courage #2 - Mari Payne

Kazuyuki Shimizu, M.D.

By IMF Admin on August 27, 2011 5:59 AM | No Comments
Kazuyuki Shimizu, M.D.

Sydney 2005:
Prevalence, Pathogenesis & Treatment of Anemia with Erythropoetic Agents in MM

By IMF Admin on August 27, 2011 4:52 AM | No Comments
Sydney 2005:
Prevalence, Pathogenesis & Treatment of Anemia with Erythropoetic Agents in MM

Rob Hain

By IMF Admin on August 27, 2011 4:14 AM | No Comments
Rob Hain

March 25, 2002: IMF Myeloma Minute Special Report - Online Chat

By IMF Admin on August 27, 2011 3:53 AM | No Comments
March 25, 2002: IMF Myeloma Minute Special Report - Online Chat

STEP 6: RESPONSE ASSESSMENT - IS TREATMENT WORKING?
REFERENCES

By IMF Admin on August 27, 2011 3:48 AM | No Comments
STEP 6: RESPONSE ASSESSMENT - IS TREATMENT WORKING?
REFERENCES

Myeloma Quilt of Courage #2 - Arlene Geczi

By IMF Admin on August 27, 2011 3:28 AM | No Comments
Myeloma Quilt of Courage #2 - Arlene Geczi

October 24, 2003 Myeloma Minute

By IMF Admin on August 27, 2011 3:09 AM | No Comments
October 24, 2003 Myeloma Minute

Become a 16th Anniversary Gala Sponsor

By IMF Admin on August 27, 2011 2:36 AM | No Comments
Become a 16th Anniversary Gala Sponsor

Music Against Myeloma

By IMF Admin on August 27, 2011 2:03 AM | No Comments
Music Against Myeloma

ThaDD vs ThaDD plus HDT in Elderly Patients with de novo MM

By IMF Admin on August 27, 2011 1:29 AM | No Comments
ThaDD vs ThaDD plus HDT in Elderly Patients with de novo MM

STEP 9: RELAPSE - DO YOU NEED A CHANGE IN TREATMENT?
REFERENCES

By IMF Admin on August 26, 2011 11:42 PM | No Comments
STEP 9: RELAPSE - DO YOU NEED A CHANGE IN TREATMENT?
REFERENCES

Prediction of response to therapy with clarithromycin/lenalidomide/dexamethasone (BIRD) in MM

By IMF Admin on August 26, 2011 11:41 PM | No Comments
Prediction of response to therapy with clarithromycin/lenalidomide/dexamethasone (BIRD) in MM

STEP 3: INITIAL TREATMENT SELECTION - GETTING THE BEST TREATMENT
REFERENCES

By IMF Admin on August 26, 2011 11:23 PM | No Comments
STEP 3: INITIAL TREATMENT SELECTION - GETTING THE BEST TREATMENT
REFERENCES

IMF Reports from 43rd ASH Annual Meeting

By IMF Admin on August 26, 2011 11:12 PM | No Comments
IMF Reports from 43rd ASH Annual Meeting

Kathy Fortier

By IMF Admin on August 26, 2011 10:30 PM | 1 Comment
Kathy Fortier

MRC Myeloma IX: Preliminary Results From The Intensive Pathway Study

By IMF Admin on August 26, 2011 9:42 PM | No Comments
MRC Myeloma IX: Preliminary Results From The Intensive Pathway Study

Leonard Zakim

By IMF Admin on August 26, 2011 9:25 PM | No Comments
Leonard Zakim

Myeloma Quilt of Courage #2 - Andre Chabot

By IMF Admin on August 26, 2011 4:45 PM | No Comments
Myeloma Quilt of Courage #2 - Andre Chabot

Jim Gambrill

By IMF Admin on August 26, 2011 4:42 PM | No Comments
Jim Gambrill

Sydney 2005: A Phase I, Multi-Dose, Dose Escalation Study of SGN-40 (anti-huCD40 mAb) ...

By IMF Admin on August 26, 2011 4:25 PM | No Comments
Sydney 2005: A Phase I, Multi-Dose, Dose Escalation Study of SGN-40 (anti-huCD40 mAb) ...

Report from the Atlanta 2005 Patient & Family Seminar

By IMF Admin on August 26, 2011 4:04 PM | No Comments
Report from the Atlanta 2005 Patient & Family Seminar

International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Tassone - Dissecting the Multiple Myeloma Tumor Microenvironment: A Novel In Vivo Platform

By IMF Admin on August 26, 2011 4:03 PM | No Comments
International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Tassone - Dissecting the Multiple Myeloma Tumor Microenvironment: A Novel In Vivo Platform

Advocacy Update: November 5, 2009

By IMF Admin on August 26, 2011 3:54 PM | No Comments
Advocacy Update: November 5, 2009

International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 1
Dr. Roodman - Consensus guidelines for the management of bone disease in multiple myeloma

By IMF Admin on August 26, 2011 2:10 PM | No Comments
International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 1
Dr. Roodman - Consensus guidelines for the management of bone disease in multiple myeloma

Update from IMW 2011: Proteasome Inhibitors
Dr. Kenneth Anderson

By IMF Admin on August 26, 2011 2:08 PM | No Comments
Update from IMW 2011: Proteasome Inhibitors
Dr. Kenneth Anderson

What's New in Research - November 19, 2002

By IMF Admin on August 26, 2011 1:57 PM | No Comments
What's New in Research - November 19, 2002

What's New In Research - September 21, 2003

By IMF Admin on August 26, 2011 1:26 PM | No Comments
What's New In Research - September 21, 2003

Lori Watson

By IMF Admin on August 26, 2011 1:12 PM | No Comments
Lori Watson

Dr. Cavo - Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities

By IMF Admin on August 26, 2011 1:07 PM | No Comments
Dr. Cavo - Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities

Dr. Ghobrial - Phase I Trial of Plerixafor and Bortezomib as a Chemosensitization Strategy In Relapsed or Relapsed/Refractory Multiple Myeloma

By IMF Admin on August 26, 2011 1:00 PM | No Comments
Dr. Ghobrial - Phase I Trial of Plerixafor and Bortezomib as a Chemosensitization Strategy In Relapsed or Relapsed/Refractory Multiple Myeloma

Dr. Richardson - A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or In Combination with Low-Dose Dexamethasone In Patients with Relapsed and Refract

By IMF Admin on August 26, 2011 12:46 PM | No Comments
Dr. Richardson - A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or In Combination with Low-Dose Dexamethasone In Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib

Dr. Knop - The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma ? First Results of a Phase II Trial by the German DSMM Group

By IMF Admin on August 26, 2011 12:42 PM | No Comments
Dr. Knop - The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma ? First Results of a Phase II Trial by the German DSMM Group

Dr. Richardson - Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study

By IMF Admin on August 26, 2011 12:30 PM | No Comments
Dr. Richardson - Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study

Dr. Vesole - Oral Antibiotic Prophylaxis of Early Infection In Multiple Myeloma: A URCC/ECOG Phase III Study

By IMF Admin on August 26, 2011 12:22 PM | No Comments
Dr. Vesole - Oral Antibiotic Prophylaxis of Early Infection In Multiple Myeloma: A URCC/ECOG Phase III Study

Dr. Harousseau - ASH 2008 - Un R

By IMF Admin on August 26, 2011 11:48 AM | No Comments
Dr. Harousseau - ASH 2008 - Un R

New! MM Interactive

By IMF Admin on August 26, 2011 11:36 AM | No Comments
New! MM Interactive

B

By IMF Admin on August 26, 2011 11:36 AM | No Comments
B

Elise Segar and Red Dot Match Funds for the IMF

By IMF Admin on August 26, 2011 11:27 AM | No Comments
Elise Segar and Red Dot Match Funds for the IMF

Myeloma Awareness Month 2009
International Myeloma Workshop 2009 Update: Patient Perspective

By IMF Admin on August 26, 2011 10:59 AM | No Comments
Myeloma Awareness Month 2009
International Myeloma Workshop 2009 Update: Patient Perspective

PRESENTATIONS FROM THE XIITH INTERNATIONAL MYELOMA WORKSHOP IN WASHINGTON, DC
FEBRUARY 26 - MARCH 1, 2009

By IMF Admin on August 26, 2011 10:57 AM | No Comments
PRESENTATIONS FROM THE XIITH INTERNATIONAL MYELOMA WORKSHOP IN WASHINGTON, DC
FEBRUARY 26 - MARCH 1, 2009

Dr. Raje - Updated Results of a Phase I Study of RAD001 In Combination with Lenalidomide In Patients with Relapsed or Refractory Multiple Myeloma with Pharmacodynamic and Pharmacokinetic Analysis

By IMF Admin on August 26, 2011 10:21 AM | No Comments
Dr. Raje - Updated Results of a Phase I Study of RAD001 In Combination with Lenalidomide In Patients with Relapsed or Refractory Multiple Myeloma with Pharmacodynamic and Pharmacokinetic Analysis

September 17, 2002 IMF Myeloma Minute

By IMF Admin on August 26, 2011 10:16 AM | No Comments
September 17, 2002 IMF Myeloma Minute

An Overview of ASH 2006

By IMF Admin on August 26, 2011 10:15 AM | No Comments
An Overview of ASH 2006

September 11, 2002 IMF Myeloma Minute

By IMF Admin on August 26, 2011 10:09 AM | No Comments
September 11, 2002 IMF Myeloma Minute

REPORT FROM THE 14th ANNIVERSARY RIBBON OF HOPE GALA

By IMF Admin on August 26, 2011 10:07 AM | No Comments
REPORT FROM THE 14th ANNIVERSARY RIBBON OF HOPE GALA

November 5, 2002 IMF Myeloma Minute

By IMF Admin on August 26, 2011 9:53 AM | No Comments
November 5, 2002 IMF Myeloma Minute

Sydney 2005:
Novel Insights into the Biology & Therapy of Waldenstrom's Macuglobulinemia

By IMF Admin on August 26, 2011 9:53 AM | No Comments
Sydney 2005:
Novel Insights into the Biology & Therapy of Waldenstrom's Macuglobulinemia

November 13, 2002 IMF Myeloma Minute

By IMF Admin on August 26, 2011 9:48 AM | No Comments
November 13, 2002 IMF Myeloma Minute

Glenn Schroer

By IMF Admin on August 26, 2011 9:39 AM | 1 Comment
Glenn Schroer

La International Myeloma Foundation e l'Associazione Schirinzi A. Mario uniscono le loro forze per la lotta contro il mieloma multiplo

By IMF Admin on August 26, 2011 9:29 AM | No Comments
La International Myeloma Foundation e l'Associazione Schirinzi A. Mario uniscono le loro forze per la lotta contro il mieloma multiplo

Advocacy Update - November 30, 2010

By IMF Admin on August 26, 2011 9:24 AM | No Comments
Advocacy Update - November 30, 2010

Val Cousins

By IMF Admin on August 26, 2011 9:03 AM | No Comments
Val Cousins

Myeloma Merkur - Dezember 2008

By IMF Admin on August 26, 2011 8:20 AM | No Comments
Myeloma Merkur - Dezember 2008

Myelom Merkur - August 2007

By IMF Admin on August 26, 2011 7:09 AM | No Comments
Myelom Merkur - August 2007

Myelom Merkur - October 2010

By IMF Admin on August 26, 2011 6:14 AM | No Comments
Myelom Merkur - October 2010

Myelom Merkur - 5. Ausgabe, January 2007

By IMF Admin on August 26, 2011 6:12 AM | No Comments
Myelom Merkur - 5. Ausgabe, January 2007

Marvin Mason

By IMF Admin on August 26, 2011 5:28 AM | No Comments
Marvin Mason

ASCO 2006

By IMF Admin on August 26, 2011 5:03 AM | No Comments
ASCO 2006

Myeloma Quilt of Courage #5 - By Myde Stocker

By IMF Admin on August 26, 2011 3:27 AM | No Comments
Myeloma Quilt of Courage #5 - By Myde Stocker

Dr. Ghobrial - Final Results of the Phase I/II Trial of Weekly Bortezomib In Combination with Temsirolimus (CCI-779) In Relapsed or Relapsed/Refractory Multiple Myeloma Specifically In Patients Refractory to Bortezomib

By IMF Admin on August 26, 2011 2:55 AM | No Comments
Dr. Ghobrial - Final Results of the Phase I/II Trial of Weekly Bortezomib In Combination with Temsirolimus (CCI-779) In Relapsed or Relapsed/Refractory Multiple Myeloma Specifically In Patients Refractory to Bortezomib

Joanie Pinson

By IMF Admin on August 26, 2011 2:54 AM | No Comments
Joanie Pinson

Report from the Rome 2008 Patient and Family Seminar

By IMF Admin on August 26, 2011 1:58 AM | No Comments
Report from the Rome 2008 Patient and Family Seminar

Sydney 2005: In MM 14q32 Transloc. are Present in Memory B Cells but RAS Mutations are Restricted...

By IMF Admin on August 25, 2011 10:54 PM | No Comments
Sydney 2005: In MM 14q32 Transloc. are Present in Memory B Cells but RAS Mutations are Restricted...

Comedy Celebration 2009 Journal Specifications and Submission Requirements

By IMF Admin on August 25, 2011 10:46 PM | No Comments
Comedy Celebration 2009 Journal Specifications and Submission Requirements

Improving Care for Patients with Amyloidosis

By IMF Admin on August 25, 2011 10:09 PM | No Comments
Improving Care for Patients with Amyloidosis

Jayesh Mehta, MD

By IMF Admin on August 25, 2011 9:17 PM | No Comments
Jayesh Mehta, MD

IMF Nurse Leadership Board (NLB) Survivorship Care Plan for Mutliple Myeloma published this month in the Clinical Journal of Oncology Nursing.

By IMF Admin on August 25, 2011 7:59 PM | 1 Comment
IMF Nurse Leadership Board (NLB) Survivorship Care Plan for Mutliple Myeloma published this month in the Clinical Journal of Oncology Nursing.

IMF Launches Innovative New Program for Support Groups

By IMF Admin on August 25, 2011 7:42 PM | No Comments
IMF Launches Innovative New Program for Support Groups

IMPORTANT PHILADELPHIA PATIENT & FAMILY SEMINAR UPDATE!

By IMF Admin on August 25, 2011 3:03 PM | No Comments
IMPORTANT PHILADELPHIA PATIENT & FAMILY SEMINAR UPDATE!

IMPORTANT PHILADELPHIA PATIENT & FAMILY SEMINAR UPDATE!

By IMF Admin on August 25, 2011 3:03 PM | No Comments
IMPORTANT PHILADELPHIA PATIENT & FAMILY SEMINAR UPDATE!

IMPORTANT PHILADELPHIA PATIENT & FAMILY SEMINAR UPDATE!

By IMF Admin on August 25, 2011 3:03 PM | No Comments
IMPORTANT PHILADELPHIA PATIENT & FAMILY SEMINAR UPDATE!

Sydney 2005:
Maintenance Therapy After Autologous Stem Cell Transplantation: IFM99 Trial

By IMF Admin on August 25, 2011 2:34 PM | No Comments
Sydney 2005:
Maintenance Therapy After Autologous Stem Cell Transplantation: IFM99 Trial

Questions and Answers about Stem Cell Transplantation

By IMF Admin on August 25, 2011 1:57 PM | No Comments
Questions and Answers about Stem Cell Transplantation

House Budget Committee is Next Funding Hurdle

By IMF Admin on August 25, 2011 1:56 PM | No Comments
House Budget Committee is Next Funding Hurdle

Myeloma Quilt of Courage #3 - Pat Hall

By IMF Admin on August 25, 2011 1:56 PM | No Comments
Myeloma Quilt of Courage #3 - Pat Hall

Sydney 2005: Tumor Antigen Immunization of Human Allotransplant Donors in Myeloma

By IMF Admin on August 25, 2011 12:46 PM | No Comments
Sydney 2005: Tumor Antigen Immunization of Human Allotransplant Donors in Myeloma

Myeloma Quilt of Courage #1 - Dr. Michael Braver

By IMF Admin on August 25, 2011 11:11 AM | No Comments
Myeloma Quilt of Courage #1 - Dr. Michael Braver

August 20, 2002 IMF Myeloma Minute

By IMF Admin on August 25, 2011 11:10 AM | No Comments
August 20, 2002 IMF Myeloma Minute

March 19, 2002: IMF Myeloma Minute

By IMF Admin on August 25, 2011 11:08 AM | No Comments
March 19, 2002: IMF Myeloma Minute

Sydney 2005:
HDT Options for Elderly Myeloma Patients: Results of a Randomized Controlled Trial

By IMF Admin on August 25, 2011 10:36 AM | No Comments
Sydney 2005:
HDT Options for Elderly Myeloma Patients: Results of a Randomized Controlled Trial

LLM ACT: Leukemia, Lymphoma and Myeloma: Action, Communication, Teamwork

By IMF Admin on August 25, 2011 9:56 AM | No Comments
LLM ACT: Leukemia, Lymphoma and Myeloma: Action, Communication, Teamwork

Long-Term Survivorship Guidelines for Multiple Myeloma Patients
The IMF NLB Survivorship Care Plan by Joseph Tariman, PhD, APRN, BC

By IMF Admin on August 25, 2011 9:23 AM | No Comments
Long-Term Survivorship Guidelines for Multiple Myeloma Patients
The IMF NLB Survivorship Care Plan by Joseph Tariman, PhD, APRN, BC

Long-Term Survivorship Guidelines for Multiple Myeloma Patients
Elizabeth Bilotti, MSN, APRN, BC

By IMF Admin on August 25, 2011 9:21 AM | No Comments
Long-Term Survivorship Guidelines for Multiple Myeloma Patients
Elizabeth Bilotti, MSN, APRN, BC

Long-Term Survivorship Guidelines for Multiple Myeloma Patients
Welcome and Introduction by Beth Faiman, MSN, APRIN-BC, AOCN

By IMF Admin on August 25, 2011 9:19 AM | No Comments
Long-Term Survivorship Guidelines for Multiple Myeloma Patients
Welcome and Introduction by Beth Faiman, MSN, APRIN-BC, AOCN

Long-Term Survivorship Guidelines for Multiple Myeloma Patients
Kathleen Colson, RN, BSN, BS

By IMF Admin on August 25, 2011 9:09 AM | No Comments
Long-Term Survivorship Guidelines for Multiple Myeloma Patients
Kathleen Colson, RN, BSN, BS

June Brazil

By IMF Admin on August 25, 2011 8:59 AM | No Comments
June Brazil

IMF Promotes David Smith to Executive Director

By IMF Admin on August 25, 2011 8:35 AM | No Comments
IMF Promotes David Smith to Executive Director

Primary Treatment with Pulsed MDT in Symptomatic Elderly Patients

By IMF Admin on August 25, 2011 7:57 AM | No Comments
Primary Treatment with Pulsed MDT in Symptomatic Elderly Patients

National Cancer Institute Leukemia, Lymphoma And Myeloma Progress Review Group (PRG)

By IMF Admin on August 25, 2011 7:23 AM | No Comments
National Cancer Institute Leukemia, Lymphoma And Myeloma Progress Review Group (PRG)

Dr. Bergsagel - ASH 2008 - The Genetic Origin of Myeloma

By IMF Admin on August 25, 2011 7:01 AM | No Comments
Dr. Bergsagel - ASH 2008 - The Genetic Origin of Myeloma

Fashions-4-A-Cure Donation Form

By IMF Admin on August 25, 2011 6:46 AM | No Comments
Fashions-4-A-Cure Donation Form

What's New In Research - December 19, 2002

By IMF Admin on August 25, 2011 6:46 AM | No Comments
What's New In Research - December 19, 2002

Sydney 2005:
Overview of New Therapies and Future Directions

By IMF Admin on August 25, 2011 6:44 AM | No Comments
Sydney 2005:
Overview of New Therapies and Future Directions

2006 IMF Support Group Leaders? Retreat

By IMF Admin on August 25, 2011 6:38 AM | No Comments
2006 IMF Support Group Leaders? Retreat

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Zweegman - Report from EMNTG-Hovon/Nordic

By IMF Admin on August 25, 2011 6:33 AM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Zweegman - Report from EMNTG-Hovon/Nordic

International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Jagannath - Monoclonal Antibodies in the Treatment of Myeloma

By IMF Admin on August 25, 2011 6:31 AM | No Comments
International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Jagannath - Monoclonal Antibodies in the Treatment of Myeloma

Sydney 2005:
Is Thalidomide First Line Therapy?

By IMF Admin on August 25, 2011 6:03 AM | No Comments
Sydney 2005:
Is Thalidomide First Line Therapy?

A Phase III Study of MEL200 versus MEL100 in Newly Diagnosed Myeloma Young Patients

By IMF Admin on August 25, 2011 6:01 AM | No Comments
A Phase III Study of MEL200 versus MEL100 in Newly Diagnosed Myeloma Young Patients

One Voice Against Cancer Coalition Discusses Impact of Election

By IMF Admin on August 25, 2011 4:13 AM | No Comments
One Voice Against Cancer Coalition Discusses Impact of Election

Myelom Merkur - Mai 2008

By IMF Admin on August 25, 2011 3:58 AM | No Comments
Myelom Merkur - Mai 2008

Smoldering Myeloma (low risk)

By IMF Admin on August 25, 2011 3:05 AM | 1 Comment
Smoldering Myeloma (low risk)

Report from ASCO 2004: MYELOMA FRONTLINE THERAPY IN THE SPOTLIGHT

By IMF Admin on August 25, 2011 1:53 AM | No Comments
Report from ASCO 2004: MYELOMA FRONTLINE THERAPY IN THE SPOTLIGHT

Rodriguez ASH

By IMF Admin on August 25, 2011 1:30 AM | No Comments
Rodriguez ASH

STEP 9: RELAPSE - DO YOU NEED A CHANGE IN TREATMENT?

By IMF Admin on August 24, 2011 11:57 PM | 5 Comments
STEP 9: RELAPSE - DO YOU NEED A CHANGE IN TREATMENT?

Myeloma Minute - July 26, 2006
Part II

By IMF Admin on August 24, 2011 11:54 PM | No Comments
Myeloma Minute - July 26, 2006
Part II

The International Myeloma Foundation Issues Prevention and Treatment Guidelines for Firefighters for High-Risk Cancer

By IMF Admin on August 24, 2011 11:48 PM | No Comments
The International Myeloma Foundation Issues Prevention and Treatment Guidelines for Firefighters for High-Risk Cancer

Sept. 5, 1999 -- VIIth International Workshop On Multiple Myeloma, Stockholm, Sweden

By IMF Admin on August 24, 2011 11:25 PM | No Comments
Sept. 5, 1999 -- VIIth International Workshop On Multiple Myeloma, Stockholm, Sweden

Sydney 2005: Pegylated Doxorubicin in Combination w Immune-modulators & Arsenic

By IMF Admin on August 24, 2011 10:31 PM | No Comments
Sydney 2005: Pegylated Doxorubicin in Combination w Immune-modulators & Arsenic

IMF Welcomes Multiple Myeloma Research Consortium to Team

By IMF Admin on August 24, 2011 10:21 PM | No Comments
IMF Welcomes Multiple Myeloma Research Consortium to Team

Myeloma Minute - December 3, 2004

By IMF Admin on August 24, 2011 10:19 PM | No Comments
Myeloma Minute - December 3, 2004

May 7, 2002: IMF Myeloma Minute

By IMF Admin on August 24, 2011 9:28 PM | No Comments
May 7, 2002: IMF Myeloma Minute

May 9, 2003 Myeloma Minute

By IMF Admin on August 24, 2011 9:16 PM | No Comments
May 9, 2003 Myeloma Minute

February 27, 2003 Myeloma Minute

By IMF Admin on August 24, 2011 8:30 PM | No Comments
February 27, 2003 Myeloma Minute

What's New In Research - March 6, 2003

By IMF Admin on August 24, 2011 7:17 PM | No Comments
What's New In Research - March 6, 2003

Myeloma Quilt of Courage #3 - Isabelle Weinberg

By IMF Admin on August 24, 2011 7:11 PM | No Comments
Myeloma Quilt of Courage #3 - Isabelle Weinberg

Jack Aiello

By IMF Admin on August 24, 2011 6:22 PM | 1 Comment
Jack Aiello

How to Decide If You Need a Transplant

By IMF Admin on August 24, 2011 5:28 PM | 2 Comments
How to Decide If You Need a Transplant

Blood Drive dedicated to IMFer Michael Tuohy

By IMF Admin on August 24, 2011 5:27 PM | No Comments
Blood Drive dedicated to IMFer Michael Tuohy

G

By IMF Admin on August 24, 2011 5:21 PM | No Comments
G

Value of a Transplant

By IMF Admin on August 24, 2011 4:37 PM | No Comments
Value of a Transplant

Transplants and Clinical Trials

By IMF Admin on August 24, 2011 4:34 PM | No Comments
Transplants and Clinical Trials

Myeloma Quilt of Courage #4 - Robert Warren Evans

By IMF Admin on August 24, 2011 4:20 PM | No Comments
Myeloma Quilt of Courage #4 - Robert Warren Evans

CAUTION ABOUT USE OF ERYTHROPOIETIN PRODUCTS

By IMF Admin on August 24, 2011 4:18 PM | No Comments
CAUTION ABOUT USE OF ERYTHROPOIETIN PRODUCTS

Slide Set from the 2009 ONS Annual Congress Satellite Symposium
Leading the Way: Managing Multiple Myeloma for the Long-Term

By IMF Admin on August 24, 2011 4:16 PM | No Comments
Slide Set from the 2009 ONS Annual Congress Satellite Symposium
Leading the Way: Managing Multiple Myeloma for the Long-Term

Sydney 2005:
Normal Plasma Cell Development and Pathogenesis of MGUS and MM

By IMF Admin on August 24, 2011 3:52 PM | No Comments
Sydney 2005:
Normal Plasma Cell Development and Pathogenesis of MGUS and MM

IMF Receives Million Dollar Grant from Centers for Disease Control and Prevention

By IMF Admin on August 24, 2011 3:46 PM | No Comments
IMF Receives Million Dollar Grant from Centers for Disease Control and Prevention

New Imids

By IMF Admin on August 24, 2011 3:02 PM | No Comments
New Imids

IMF Call Me Now Service

By IMF Admin on August 24, 2011 2:57 PM | No Comments
IMF Call Me Now Service

Expert Opinions On Multiple Myeloma

By IMF Admin on August 24, 2011 2:56 PM | No Comments
Expert Opinions On Multiple Myeloma

Dr. Morgan - ASH 2008 - Maintenance Thalidomide May Improve Progression Free but Not Overall Survival; Results from the Myeloma IX Maintenance Randomisation

By IMF Admin on August 24, 2011 2:33 PM | No Comments
Dr. Morgan - ASH 2008 - Maintenance Thalidomide May Improve Progression Free but Not Overall Survival; Results from the Myeloma IX Maintenance Randomisation

Module 1 Bibliography

By IMF Admin on August 24, 2011 2:30 PM | No Comments
Module 1 Bibliography

Sydney 2005:
The Evolving vs Non-Evolving Nature of Asymptomatic Monoclonal Gammopathies

By IMF Admin on August 24, 2011 2:28 PM | No Comments
Sydney 2005:
The Evolving vs Non-Evolving Nature of Asymptomatic Monoclonal Gammopathies

Dr. Dimopoulos - Elevated Serum Lactate Dehydrogenase (LDH) Should Be Included Among the Variables Which Define High Risk Multiple myeloma

By IMF Admin on August 24, 2011 2:24 PM | No Comments
Dr. Dimopoulos - Elevated Serum Lactate Dehydrogenase (LDH) Should Be Included Among the Variables Which Define High Risk Multiple myeloma

Difference Made in New York by Nurse Leadership Board Member

By IMF Admin on August 24, 2011 2:09 PM | No Comments
Difference Made in New York by Nurse Leadership Board Member

Dr. Morgan - Optimising Bone Disease In Myeloma; Zoledronic Acid Plus Thalidomide Combinations Improves Survival and Bone Endpoints: Results of the MRC Myeloma IX Trial

By IMF Admin on August 24, 2011 2:00 PM | No Comments
Dr. Morgan - Optimising Bone Disease In Myeloma; Zoledronic Acid Plus Thalidomide Combinations Improves Survival and Bone Endpoints: Results of the MRC Myeloma IX Trial

What is a Transplant?

By IMF Admin on August 24, 2011 1:58 PM | 1 Comment
What is a Transplant?

Psychosocial Issues Surrounding Transplant

By IMF Admin on August 24, 2011 1:45 PM | No Comments
Psychosocial Issues Surrounding Transplant

Alan Solomon, MD

By IMF Admin on August 24, 2011 1:43 PM | No Comments
Alan Solomon, MD

The Transplant Procedure

By IMF Admin on August 24, 2011 12:46 PM | 1 Comment
The Transplant Procedure

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Bergsagel - t(4&14) and Genomic Instability in High-Risk Myeloma

By IMF Admin on August 24, 2011 12:26 PM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Bergsagel - t(4&14) and Genomic Instability in High-Risk Myeloma

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Morgan - The implications of High-risk Myeloma to therapy

By IMF Admin on August 24, 2011 12:23 PM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Morgan - The implications of High-risk Myeloma to therapy

WALL OF MIRACLES PARTNERS CIRCLE

By IMF Admin on August 24, 2011 12:22 PM | No Comments
WALL OF MIRACLES PARTNERS CIRCLE

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Panel Discussion

By IMF Admin on August 24, 2011 12:18 PM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Panel Discussion

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Panel Discussion

By IMF Admin on August 24, 2011 12:13 PM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Panel Discussion

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Facon - Report from IFM

By IMF Admin on August 24, 2011 12:12 PM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Facon - Report from IFM

International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Leung - Myeloma Cast Nephropathy

By IMF Admin on August 24, 2011 12:09 PM | No Comments
International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Leung - Myeloma Cast Nephropathy

International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Goldschmidt - Report from GMMG

By IMF Admin on August 24, 2011 11:59 AM | No Comments
International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Goldschmidt - Report from GMMG

International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Giuliani - Effect of New Anti-myeloma Drugs on Bone Microenvironment Cells

By IMF Admin on August 24, 2011 11:29 AM | No Comments
International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Giuliani - Effect of New Anti-myeloma Drugs on Bone Microenvironment Cells

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Stewart - Whole Genome Sequencing in high-risk Myeloma

By IMF Admin on August 24, 2011 11:15 AM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Stewart - Whole Genome Sequencing in high-risk Myeloma

July 18, 2003 Myeloma Minute

By IMF Admin on August 24, 2011 10:51 AM | No Comments
July 18, 2003 Myeloma Minute

Myeloma Minute - July 26, 2006
Part II

By IMF Admin on August 24, 2011 10:50 AM | No Comments
Myeloma Minute - July 26, 2006
Part II

International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Panel Discussion

By IMF Admin on August 24, 2011 10:36 AM | No Comments
International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Panel Discussion

Martin Oken, MD

By IMF Admin on August 24, 2011 10:25 AM | No Comments
Martin Oken, MD

Alf Lied

By IMF Admin on August 24, 2011 9:54 AM | No Comments
Alf Lied

Bank On A Cure

By IMF Admin on August 24, 2011 8:32 AM | No Comments
Bank On A Cure

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Panel Discussion

By IMF Admin on August 24, 2011 8:31 AM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Panel Discussion

Support Group Leader Retreat
June 27-29, 2003

By IMF Admin on August 24, 2011 8:12 AM | No Comments
Support Group Leader Retreat
June 27-29, 2003

Sydney 2005: Intensive v Double Intensive Tx in Untreated MM: Update of HOVON 24 MM

By IMF Admin on August 24, 2011 8:09 AM | No Comments
Sydney 2005: Intensive v Double Intensive Tx in Untreated MM: Update of HOVON 24 MM

Myeloma Quilt of Courage #2 - Gary E. Schneider

By IMF Admin on August 24, 2011 7:49 AM | 1 Comment
Myeloma Quilt of Courage #2 - Gary E. Schneider

STEP 5: TRANSPLANT - DO YOU NEED ONE?

By IMF Admin on August 24, 2011 7:41 AM | 1 Comment
STEP 5: TRANSPLANT - DO YOU NEED ONE?

Sydney 2005: Single v Double HDT in MM: Second Analysis of the Trial GMMG-HD2

By IMF Admin on August 24, 2011 7:40 AM | No Comments
Sydney 2005: Single v Double HDT in MM: Second Analysis of the Trial GMMG-HD2

Myeloma Minute

By IMF Admin on August 24, 2011 7:29 AM | No Comments
Myeloma Minute

Sydney 2005: Microarray Exp. Profiling Indicates Upreg. of Ribosomal Machinery in del(13)-Neg Clone

By IMF Admin on August 24, 2011 7:16 AM | No Comments
Sydney 2005: Microarray Exp. Profiling Indicates Upreg. of Ribosomal Machinery in del(13)-Neg Clone

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combinat

By IMF Admin on August 24, 2011 7:00 AM | No Comments
Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

Myeloma Quilt of Courage #3 - Lynn Betts

By IMF Admin on August 24, 2011 6:56 AM | No Comments
Myeloma Quilt of Courage #3 - Lynn Betts

IL-17 Promotes Tumor Cell Growth & Survival, and Inhibits Immune Function in Myeloma

By IMF Admin on August 24, 2011 6:53 AM | No Comments
IL-17 Promotes Tumor Cell Growth & Survival, and Inhibits Immune Function in Myeloma

Sydney 2005:
Cross-talks Between Plasma Cells and the Microenvironment: Triggering and Targeting

By IMF Admin on August 24, 2011 6:14 AM | No Comments
Sydney 2005:
Cross-talks Between Plasma Cells and the Microenvironment: Triggering and Targeting

Pieter Sonneveld, MD

By IMF Admin on August 24, 2011 5:02 AM | No Comments
Pieter Sonneveld, MD

Summary of the Xth International Myeloma Workshop

By IMF Admin on August 24, 2011 4:54 AM | No Comments
Summary of the Xth International Myeloma Workshop

International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Nobile-Orazio - Neuropathy in Monoclonal Gammopathy

By IMF Admin on August 24, 2011 4:45 AM | No Comments
International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Nobile-Orazio - Neuropathy in Monoclonal Gammopathy

Forming A Support Group - Sample Flyer

By IMF Admin on August 24, 2011 4:21 AM | No Comments
Forming A Support Group - Sample Flyer

Myeloma Quilt of Courage #3 - Samona Creasy

By IMF Admin on August 24, 2011 4:19 AM | No Comments
Myeloma Quilt of Courage #3 - Samona Creasy

Overview of Treatment Options

By IMF Admin on August 24, 2011 4:04 AM | No Comments
Overview of Treatment Options

Module 2: First-Line Treament of Multiple Myeloma

By IMF Admin on August 24, 2011 3:38 AM | No Comments
Module 2: First-Line Treament of Multiple Myeloma

Case Presentation and Interactive Case Discussion

By IMF Admin on August 24, 2011 3:35 AM | No Comments
Case Presentation and Interactive Case Discussion

Dr. Lokhorst - ASH 2008 - Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)

By IMF Admin on August 24, 2011 3:19 AM | No Comments
Dr. Lokhorst - ASH 2008 - Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)

What's New In Research - March 11, 2003

By IMF Admin on August 24, 2011 3:07 AM | No Comments
What's New In Research - March 11, 2003

Sydney 2005:
Intercellulalar Communication Signals Determined by Gene Expression Profiling in MM

By IMF Admin on August 24, 2011 3:04 AM | No Comments
Sydney 2005:
Intercellulalar Communication Signals Determined by Gene Expression Profiling in MM

Myeloma Quilt of Courage #4 - Butterfly

By IMF Admin on August 24, 2011 2:16 AM | No Comments
Myeloma Quilt of Courage #4 - Butterfly

ASH 2005 Webcast - Development Of The Custom SNP Chip For BOAC

By IMF Admin on August 24, 2011 2:02 AM | No Comments
ASH 2005 Webcast - Development Of The Custom SNP Chip For BOAC

Sydney 2005:
Epidemiology of Multiple Myeloma

By IMF Admin on August 24, 2011 2:00 AM | No Comments
Sydney 2005:
Epidemiology of Multiple Myeloma

Bericht

By IMF Admin on August 24, 2011 1:29 AM | No Comments
Bericht

Targeting the Translational Machinery in Multiple Myeloma

By IMF Admin on August 24, 2011 1:28 AM | No Comments
Targeting the Translational Machinery in Multiple Myeloma

The IMF at Work in Washington

By IMF Admin on August 24, 2011 12:40 AM | No Comments
The IMF at Work in Washington

Pilot Study Evaluating the Safety & Efficacy of AMD3100 ...

By IMF Admin on August 24, 2011 12:19 AM | No Comments
Pilot Study Evaluating the Safety & Efficacy of AMD3100 ...

Dallas 2005 Patient & Family Seminar

By IMF Admin on August 23, 2011 11:20 PM | No Comments
Dallas 2005 Patient & Family Seminar

ASCO 2006

By IMF Admin on August 23, 2011 11:07 PM | No Comments
ASCO 2006

Sydney 2005:
RANK and MIP-1alpha in MM: Clinical Implications

By IMF Admin on August 23, 2011 10:57 PM | No Comments
Sydney 2005:
RANK and MIP-1alpha in MM: Clinical Implications

Sydney 2005: Associations of Genetic Variation with Clinical Outcome: Update on Bank On A Cure

By IMF Admin on August 23, 2011 10:39 PM | No Comments
Sydney 2005: Associations of Genetic Variation with Clinical Outcome: Update on Bank On A Cure

August 2, 2003 Myeloma Minute

By IMF Admin on August 23, 2011 9:50 PM | No Comments
August 2, 2003 Myeloma Minute

Myelom Merkur - Mai 2010

By IMF Admin on August 23, 2011 8:37 PM | No Comments
Myelom Merkur - Mai 2010

William Matsui, MD, The Myeloma Stem Cell

By IMF Admin on August 23, 2011 7:09 PM | No Comments
William Matsui, MD, The Myeloma Stem Cell

Slide Set from the 2010 ONS Annual Congress Satellite Symposium
Changing Patient Care in Multiple Myeloma: The IMF Nurse Leadership Board?s Long-Term Survivorship Care Plan

By IMF Admin on August 23, 2011 7:04 PM | No Comments
Slide Set from the 2010 ONS Annual Congress Satellite Symposium
Changing Patient Care in Multiple Myeloma: The IMF Nurse Leadership Board?s Long-Term Survivorship Care Plan

October 26, 2001 Myeloma Minute

By IMF Admin on August 23, 2011 7:03 PM | No Comments
October 26, 2001 Myeloma Minute

14th Anniversary Ribbon of Hope Gala Auction - Entertainment

By IMF Admin on August 23, 2011 6:44 PM | No Comments
14th Anniversary Ribbon of Hope Gala Auction - Entertainment

14th Anniversary Ribbon of Hope Gala Auction - Travel

By IMF Admin on August 23, 2011 6:44 PM | No Comments
14th Anniversary Ribbon of Hope Gala Auction - Travel

Benjamin Van Camp, MD Ph.D.

By IMF Admin on August 23, 2011 6:34 PM | No Comments
Benjamin Van Camp, MD Ph.D.

1998 IMF Research Grant Awards

By IMF Admin on August 23, 2011 6:11 PM | No Comments
1998 IMF Research Grant Awards

Carl Jenkins

By IMF Admin on August 23, 2011 6:10 PM | No Comments
Carl Jenkins

Living Well with Multiple Myeloma teleconference series concludes November 19th with Hope, Stress, Myeloma & The Holidays.

By IMF Admin on August 23, 2011 6:01 PM | No Comments
Living Well with Multiple Myeloma teleconference series concludes November 19th with Hope, Stress, Myeloma & The Holidays.

Question for the Hotline? Use Click to Talk!

By IMF Admin on August 23, 2011 6:01 PM | No Comments
Question for the Hotline? Use Click to Talk!

Joan Blad

By IMF Admin on August 23, 2011 5:52 PM | No Comments
Joan Blad

Sydney 2005: Cancer Vaccine Treatment and Antibody Therapy in MM

By IMF Admin on August 23, 2011 5:45 PM | No Comments
Sydney 2005: Cancer Vaccine Treatment and Antibody Therapy in MM

Sydney 2005: Toward the Elucidation of the Role of Altered Wnt Signaling MM

By IMF Admin on August 23, 2011 5:43 PM | No Comments
Sydney 2005: Toward the Elucidation of the Role of Altered Wnt Signaling MM

Sydney 2005:
Bisphosphonates and the Bone Microenvironment

By IMF Admin on August 23, 2011 5:42 PM | No Comments
Sydney 2005:
Bisphosphonates and the Bone Microenvironment

Richie Test

By IMF Admin on August 23, 2011 5:40 PM | No Comments
Richie Test

International Myeloma Foundation Supports Senator Hutchison Initiative

By IMF Admin on August 23, 2011 5:20 PM | No Comments
International Myeloma Foundation Supports Senator Hutchison Initiative

November 26, 2003 Myeloma Minute

By IMF Admin on August 23, 2011 4:48 PM | No Comments
November 26, 2003 Myeloma Minute

CAL-101 a Selective Inhibitor of PI3K p110δ for the Treatment of Multiple Myeloma

By IMF Admin on August 23, 2011 4:48 PM | No Comments
CAL-101 a Selective Inhibitor of PI3K p110δ for the Treatment of Multiple Myeloma

IMPORTANT INFORMATION ABOUT THE MEDICARE DEMONSTRATION PROGRAM

By IMF Admin on August 23, 2011 4:27 PM | No Comments
IMPORTANT INFORMATION ABOUT THE MEDICARE DEMONSTRATION PROGRAM

Sydney 2005: CHIR-258, a Novel Multi-Targeted Tyrosine Kinase Inhibitor, for the Tx of t(4;14) MM

By IMF Admin on August 23, 2011 3:30 PM | No Comments
Sydney 2005: CHIR-258, a Novel Multi-Targeted Tyrosine Kinase Inhibitor, for the Tx of t(4;14) MM

SUPPORTIVE CARE AND THE MANAGEMENT OF THE NEWLY DIAGNOSED AND INITIALLY RELAPSING PATIENT

By IMF Admin on August 23, 2011 3:17 PM | No Comments
SUPPORTIVE CARE AND THE MANAGEMENT OF THE NEWLY DIAGNOSED AND INITIALLY RELAPSING PATIENT

Sydney 2005: Phenotypic and Functional Alterations of Gamma/Delta T Cells in Myeloma

By IMF Admin on August 23, 2011 2:42 PM | No Comments
Sydney 2005: Phenotypic and Functional Alterations of Gamma/Delta T Cells in Myeloma

Patient Care

By IMF Admin on August 23, 2011 2:38 PM | No Comments
Patient Care

Dr. Goldschmidt - Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and t(4;14) - a Subgroup Analysis of the HOVON-65/GMMG-HD4 Tr

By IMF Admin on August 23, 2011 2:26 PM | No Comments
Dr. Goldschmidt - Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and t(4;14) - a Subgroup Analysis of the HOVON-65/GMMG-HD4 Trial

Sydney 2005:
Alternative Gene Splicing in Myeloma; Aberrant Splicing of Hyalur.

By IMF Admin on August 23, 2011 2:05 PM | No Comments
Sydney 2005:
Alternative Gene Splicing in Myeloma; Aberrant Splicing of Hyalur.

Dear Reader

By IMF Admin on August 23, 2011 12:57 PM | No Comments
Dear Reader

Dr. Gramatzki - ASH 2008 - Ein

By IMF Admin on August 23, 2011 12:41 PM | No Comments
Dr. Gramatzki - ASH 2008 - Ein

Sydney 2005:
Is Double Autograft the Standard of Care?

By IMF Admin on August 23, 2011 12:40 PM | No Comments
Sydney 2005:
Is Double Autograft the Standard of Care?

Sydney 2005: Antagonist Anti-CD40 antibody CHIR-12.12 Causes Tumour Regr. & Prolongs Survival in MM

By IMF Admin on August 23, 2011 12:39 PM | No Comments
Sydney 2005: Antagonist Anti-CD40 antibody CHIR-12.12 Causes Tumour Regr. & Prolongs Survival in MM

New Data From Velcade(TM) For Injection Crest Study Indicate Responses In Patients With MM

By IMF Admin on August 23, 2011 12:35 PM | No Comments
New Data From Velcade(TM) For Injection Crest Study Indicate Responses In Patients With MM

Jack Aiello's Blog from ASH 2006

By IMF Admin on August 23, 2011 12:25 PM | No Comments
Jack Aiello's Blog from ASH 2006

Dr. Kumar - ASH 2008 - Stem Cell Mobilization Following Initial Therapy with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

By IMF Admin on August 23, 2011 12:24 PM | No Comments
Dr. Kumar - ASH 2008 - Stem Cell Mobilization Following Initial Therapy with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

Support Group Leader Blogs from ASH 2006

By IMF Admin on August 23, 2011 12:14 PM | No Comments
Support Group Leader Blogs from ASH 2006

IMF Receives Four-Star Rating from America's Largest Charity Evaluator

By IMF Admin on August 23, 2011 11:54 AM | No Comments
IMF Receives Four-Star Rating from America's Largest Charity Evaluator

Maggie O'Hara

By IMF Admin on August 23, 2011 11:41 AM | No Comments
Maggie O'Hara

Sue Sumpter's Blog from ASH 2006

By IMF Admin on August 23, 2011 11:24 AM | No Comments
Sue Sumpter's Blog from ASH 2006

Len/Dex+/-Bortezomib for Advanced Myeloma According to Prior Neuropathy: the Impact of Cytogenetics

By IMF Admin on August 23, 2011 11:19 AM | No Comments
Len/Dex+/-Bortezomib for Advanced Myeloma According to Prior Neuropathy: the Impact of Cytogenetics

Final Phase II Data Presented from VELCADE(TM) for Injection Summit Trial

By IMF Admin on August 23, 2011 11:07 AM | No Comments
Final Phase II Data Presented from VELCADE(TM) for Injection Summit Trial

Bank On A Cure® at ASH 2007

By IMF Admin on August 23, 2011 10:33 AM | No Comments
Bank On A Cure® at ASH 2007

H

By IMF Admin on August 23, 2011 10:14 AM | No Comments
H

Myeloma Awareness Month 2009
International Myeloma Workshop 2009 Update: What's of Importance to Patients for Their Future

By IMF Admin on August 23, 2011 10:06 AM | No Comments
Myeloma Awareness Month 2009
International Myeloma Workshop 2009 Update: What's of Importance to Patients for Their Future

LIGHTS, CAMERA, CURE! The IMF's 15th Anniversary Gala a Winner!

By IMF Admin on August 23, 2011 9:54 AM | No Comments
LIGHTS, CAMERA, CURE! The IMF's 15th Anniversary Gala a Winner!

Help Support the Creation of a Multiple Myeloma Awareness Stamp

By IMF Admin on August 23, 2011 9:48 AM | No Comments
Help Support the Creation of a Multiple Myeloma Awareness Stamp

Special Interview With Julian Adams, Developer Of Velcade

By IMF Admin on August 23, 2011 9:45 AM | No Comments
Special Interview With Julian Adams, Developer Of Velcade

History is Made with the First Meeting of the Israeli Myeloma Study Group

By IMF Admin on August 23, 2011 9:13 AM | No Comments
History is Made with the First Meeting of the Israeli Myeloma Study Group

IMF 2000 Research Grant Awards

By IMF Admin on August 23, 2011 8:54 AM | No Comments
IMF 2000 Research Grant Awards

Sydney 2005:
Epigenetic Changes in the Molecular Pathology of Multiple Myeloma

By IMF Admin on August 23, 2011 8:46 AM | No Comments
Sydney 2005:
Epigenetic Changes in the Molecular Pathology of Multiple Myeloma

Comedy Celebration 2009 Event Sponsors

By IMF Admin on August 23, 2011 8:41 AM | No Comments
Comedy Celebration 2009 Event Sponsors

Myeloma Quilt of Courage #1 - Frances Lopes

By IMF Admin on August 23, 2011 8:40 AM | No Comments
Myeloma Quilt of Courage #1 - Frances Lopes

Future Directions in Multiple Myeloma Treatment. What can we Expect in the Next 10 Years?

By IMF Admin on August 23, 2011 7:49 AM | No Comments
Future Directions in Multiple Myeloma Treatment. What can we Expect in the Next 10 Years?

Paula Van Riper's Blog from ASH 2006

By IMF Admin on August 23, 2011 7:48 AM | No Comments
Paula Van Riper's Blog from ASH 2006

The IMF Latin America

By IMF Admin on August 23, 2011 7:24 AM | No Comments
The IMF Latin America

Sydney 2005: Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in MM Cells ...

By IMF Admin on August 23, 2011 7:24 AM | No Comments
Sydney 2005: Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in MM Cells ...

Myeloma Quilt of Courage #1 - Dorothy Dhesse

By IMF Admin on August 23, 2011 7:22 AM | No Comments
Myeloma Quilt of Courage #1 - Dorothy Dhesse

Combination Therapy with VELCADE plus Melphalan & Prednisone

By IMF Admin on August 23, 2011 7:13 AM | No Comments
Combination Therapy with VELCADE plus Melphalan & Prednisone

Deep Vein Thrombosis (DVT) Prophylaxis

By IMF Admin on August 23, 2011 6:54 AM | No Comments
Deep Vein Thrombosis (DVT) Prophylaxis

William Bensinger, MD, Fred Hutchison Cancer Research Center, Seattle, WA

By IMF Admin on August 23, 2011 6:52 AM | No Comments
William Bensinger, MD, Fred Hutchison Cancer Research Center, Seattle, WA

Sydney 2005:
Pathogenesis of Myeloma Bone Disease

By IMF Admin on August 23, 2011 6:38 AM | No Comments
Sydney 2005:
Pathogenesis of Myeloma Bone Disease

Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone.

By IMF Admin on August 23, 2011 6:08 AM | No Comments
Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone.

Current status of stem cell transplantation: When? How Many? Allogeneic v Autologous or Both?

By IMF Admin on August 23, 2011 6:06 AM | No Comments
Current status of stem cell transplantation: When? How Many? Allogeneic v Autologous or Both?

What is an M spike and is it different from the M Protein?

By IMF Admin on August 23, 2011 6:00 AM | No Comments
What is an M spike and is it different from the M Protein?

Thank You to the Sponsors of the IMF Website!

By IMF Admin on August 23, 2011 5:59 AM | No Comments
Thank You to the Sponsors of the IMF Website!

The Role Of Osteoclast Differentiation Factor TRANCE in Myeloma-Associated Bone Destruction

By IMF Admin on August 23, 2011 5:57 AM | No Comments
The Role Of Osteoclast Differentiation Factor TRANCE in Myeloma-Associated Bone Destruction

Dr. Kumar - Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

By IMF Admin on August 23, 2011 5:22 AM | No Comments
Dr. Kumar - Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study

Sydney 2005:
New Antiangiogenic Agents

By IMF Admin on August 23, 2011 5:14 AM | No Comments
Sydney 2005:
New Antiangiogenic Agents

Multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dex vs dex

By IMF Admin on August 23, 2011 3:52 AM | No Comments
Multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dex vs dex

I'm Not Leavin'
by Michael Tuohy

By IMF Admin on August 23, 2011 3:48 AM | No Comments
I'm Not Leavin'
by Michael Tuohy

Myeloma Quilt of Courage #5 - In Memory of Nancy Ann Phillips

By IMF Admin on August 23, 2011 3:41 AM | No Comments
Myeloma Quilt of Courage #5 - In Memory of Nancy Ann Phillips

Advocacy Update - December 17, 2009

By IMF Admin on August 23, 2011 1:56 AM | No Comments
Advocacy Update - December 17, 2009

Sydney 2005: Strategies to Improve the Graft v MM Effect of Allo SCT & Donor Lymphocyte Infusions

By IMF Admin on August 23, 2011 1:37 AM | No Comments
Sydney 2005: Strategies to Improve the Graft v MM Effect of Allo SCT & Donor Lymphocyte Infusions

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Barlogie - What is GEP-defined high-risk Myeloma?

By IMF Admin on August 23, 2011 1:21 AM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Barlogie - What is GEP-defined high-risk Myeloma?

I met Dr. Brian Durie more than 30 years ago...

By IMF Admin on August 23, 2011 12:40 AM | No Comments
I met Dr. Brian Durie more than 30 years ago...

Sydney 2005:
What Have the Transplant Registries Taught Us?

By IMF Admin on August 23, 2011 12:31 AM | No Comments
Sydney 2005:
What Have the Transplant Registries Taught Us?

Dr. Niesvizky - Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients

By IMF Admin on August 23, 2011 12:29 AM | No Comments
Dr. Niesvizky - Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients

Solitary Plasmacytoma of Bone

By IMF Admin on August 23, 2011 12:26 AM | 1 Comment
Solitary Plasmacytoma of Bone

The Role of Histone Deacetylases in Drug Resistance of Multiple Myeloma Cells

By IMF Admin on August 23, 2011 12:05 AM | No Comments
The Role of Histone Deacetylases in Drug Resistance of Multiple Myeloma Cells

J. Anthony Child, MD

By IMF Admin on August 22, 2011 11:59 PM | No Comments
J. Anthony Child, MD

Sydney 2005: Inhibition of Human Plasmacytoma Cell Growth by a Novel JAK Kinase Inhibitor

By IMF Admin on August 22, 2011 11:45 PM | No Comments
Sydney 2005: Inhibition of Human Plasmacytoma Cell Growth by a Novel JAK Kinase Inhibitor

STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED?

By IMF Admin on August 22, 2011 11:39 PM | 1 Comment
STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED?

Dr. Sezer - Ein

By IMF Admin on August 22, 2011 11:32 PM | No Comments
Dr. Sezer - Ein

SPREAD THE WORD!

By IMF Admin on August 22, 2011 11:22 PM | No Comments
SPREAD THE WORD!

Multiple Myeloma Awareness Week 2008
October 20-26, 2008

By IMF Admin on August 22, 2011 11:19 PM | No Comments
Multiple Myeloma Awareness Week 2008
October 20-26, 2008

Jesus Fernando San Miguel

By IMF Admin on August 22, 2011 11:18 PM | 1 Comment
Jesus Fernando San Miguel

Slide Set from the 2010 ONS Annual Congress Satellite Symposium
Changing Patient Care in Multiple Myeloma: The IMF Nurse Leadership Board?s Long-Term Survivorship Care Plan

By IMF Admin on August 22, 2011 11:03 PM | No Comments
Slide Set from the 2010 ONS Annual Congress Satellite Symposium
Changing Patient Care in Multiple Myeloma: The IMF Nurse Leadership Board?s Long-Term Survivorship Care Plan

Advocates Needed to Contact Congress to Increase Medical Research Funding

By IMF Admin on August 22, 2011 11:02 PM | No Comments
Advocates Needed to Contact Congress to Increase Medical Research Funding

A TEA IN D.C.

By IMF Admin on August 22, 2011 10:36 PM | No Comments
A TEA IN D.C.

April 16, 2002: IMF Myeloma Minute

By IMF Admin on August 22, 2011 10:35 PM | No Comments
April 16, 2002: IMF Myeloma Minute

Lethal and bortezomib-sensitizing targets in myeloma identified by genome-scale RNAi Screening

By IMF Admin on August 22, 2011 10:20 PM | No Comments
Lethal and bortezomib-sensitizing targets in myeloma identified by genome-scale RNAi Screening

Dr. Zamagni - Prognostic Relevance of 18F-FDG PET/CT In Newly Diagnosed Multiple Myeloma Patients Treated with up-Front Autologous Transplantation: A Prospective Study

By IMF Admin on August 22, 2011 10:12 PM | No Comments
Dr. Zamagni - Prognostic Relevance of 18F-FDG PET/CT In Newly Diagnosed Multiple Myeloma Patients Treated with up-Front Autologous Transplantation: A Prospective Study

Multiple Myeloma: New Insights and Therapeutic Approaches

By IMF Admin on August 22, 2011 10:10 PM | No Comments
Multiple Myeloma: New Insights and Therapeutic Approaches

Myeloma Awareness Month 2011 ? An update on the management of the side effects of myeloma and novel agents.
March 3rd

By IMF Admin on August 22, 2011 9:09 PM | No Comments
Myeloma Awareness Month 2011 ? An update on the management of the side effects of myeloma and novel agents.
March 3rd

Dr. Raje - Bone Marker Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK Study

By IMF Admin on August 22, 2011 8:56 PM | No Comments
Dr. Raje - Bone Marker Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK Study

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Palumbo - Report from EMNTG-GIMEMA

By IMF Admin on August 22, 2011 8:25 PM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Palumbo - Report from EMNTG-GIMEMA

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Palumbo - Report from EMNTG-GIMEMA

By IMF Admin on August 22, 2011 8:25 PM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Palumbo - Report from EMNTG-GIMEMA

Myeloma Quilt of Courage #4 - Vincent Faber

By IMF Admin on August 22, 2011 8:06 PM | No Comments
Myeloma Quilt of Courage #4 - Vincent Faber

Myeloma Minute - June 9, 2005

By IMF Admin on August 22, 2011 7:55 PM | No Comments
Myeloma Minute - June 9, 2005

Dr. Wijermans - ASH 2008 - Melphalan + Prednisone Versus Melphalan + Prednisone + Thalidomide in Induction Therapy for Multiple Myeloma in Elderly Patients: Final Analysis of the Dutch Cooperative Group HOVON 49 Study

By IMF Admin on August 22, 2011 7:52 PM | No Comments
Dr. Wijermans - ASH 2008 - Melphalan + Prednisone Versus Melphalan + Prednisone + Thalidomide in Induction Therapy for Multiple Myeloma in Elderly Patients: Final Analysis of the Dutch Cooperative Group HOVON 49 Study

WALL OF MIRACLES FOUNDERS CIRCLE

By IMF Admin on August 22, 2011 7:48 PM | No Comments
WALL OF MIRACLES FOUNDERS CIRCLE

May 28, 2002: IMF Myeloma Minute

By IMF Admin on August 22, 2011 7:46 PM | No Comments
May 28, 2002: IMF Myeloma Minute

Early studies indicate targeted radioactive drug may expand treatment options for myeloma

By IMF Admin on August 22, 2011 7:30 PM | No Comments
Early studies indicate targeted radioactive drug may expand treatment options for myeloma

Myeloma Minute - March 20, 2005

By IMF Admin on August 22, 2011 7:05 PM | No Comments
Myeloma Minute - March 20, 2005

International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Panel Discussion

By IMF Admin on August 22, 2011 6:40 PM | No Comments
International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Panel Discussion

Bernard Pilcher

By IMF Admin on August 22, 2011 6:29 PM | No Comments
Bernard Pilcher

Dr. Reece - ASH 2008 - The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

By IMF Admin on August 22, 2011 5:32 PM | No Comments
Dr. Reece - ASH 2008 - The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

Heinz Ludwig ASH 2005

By IMF Admin on August 22, 2011 5:24 PM | No Comments
Heinz Ludwig ASH 2005

Myeloma Minute - March 14, 2006

By IMF Admin on August 22, 2011 5:21 PM | No Comments
Myeloma Minute - March 14, 2006

Myeloma Minute Special ASH Overview Issue

By IMF Admin on August 22, 2011 4:54 PM | No Comments
Myeloma Minute Special ASH Overview Issue

Update From ASCO 2004: Ivan Borrello, MD, Johns Hopkins University, Baltimore, MD

By IMF Admin on August 22, 2011 4:41 PM | No Comments
Update From ASCO 2004: Ivan Borrello, MD, Johns Hopkins University, Baltimore, MD

Helen Bos

By IMF Admin on August 22, 2011 4:28 PM | 1 Comment
Helen Bos

Igor Sill

By IMF Admin on August 22, 2011 4:19 PM | No Comments
Igor Sill

IMF Satellite Symposium: Key Myeloma Questions for 2010
Diagnosis, Prognosis, and Risk Assessment in Multiple Myeloma

By IMF Admin on August 22, 2011 4:14 PM | No Comments
IMF Satellite Symposium: Key Myeloma Questions for 2010
Diagnosis, Prognosis, and Risk Assessment in Multiple Myeloma

Sydney 2005:
Angiogenesis in Myeloma - An Overview

By IMF Admin on August 22, 2011 3:56 PM | No Comments
Sydney 2005:
Angiogenesis in Myeloma - An Overview

A Note from Michael McKean: "I?m a little overwhelmed by your gratitude."

By IMF Admin on August 22, 2011 3:37 PM | No Comments
A Note from Michael McKean: "I?m a little overwhelmed by your gratitude."

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Richardson - A phase 1/2 multi-center, randomized, open label dose escalation study to determine the maximum tolerated dose, safety, and efficacy of pomalidomide alone or in com

By IMF Admin on August 22, 2011 2:14 PM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Richardson - A phase 1/2 multi-center, randomized, open label dose escalation study to determine the maximum tolerated dose, safety, and efficacy of pomalidomide alone or in combination with low-dose dexamethasone in patients with relapsed and refractory Multiple Myeloma who have received prior treatment that includes lenalidomide and bortezomib

International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Cavo - Report from EMNTG-HOVON-GIMEMA

By IMF Admin on August 22, 2011 2:08 PM | No Comments
International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Cavo - Report from EMNTG-HOVON-GIMEMA

Ian Franklin, MD

By IMF Admin on August 22, 2011 1:56 PM | No Comments
Ian Franklin, MD

Multiple Myeloma Quilt of Courage #5 - To Military and Ex-Military

By IMF Admin on August 22, 2011 1:43 PM | No Comments
Multiple Myeloma Quilt of Courage #5 - To Military and Ex-Military

Phase I/II VELCADE® Clinical Trials

By IMF Admin on August 22, 2011 1:30 PM | No Comments
Phase I/II VELCADE® Clinical Trials

International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Lichtenstein - mTOR Complex Pathway in Myeloma

By IMF Admin on August 22, 2011 1:04 PM | No Comments
International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Lichtenstein - mTOR Complex Pathway in Myeloma

International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Lichtenstein - mTOR Complex Pathway in Myeloma

By IMF Admin on August 22, 2011 1:04 PM | No Comments
International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Lichtenstein - mTOR Complex Pathway in Myeloma

Living Well with Myeloma Teleconference - Hope, Stress, Myeloma & The Holidays

By IMF Admin on August 22, 2011 1:03 PM | No Comments
Living Well with Myeloma Teleconference - Hope, Stress, Myeloma & The Holidays

Living Well with Myeloma Teleconference - Hope, Stress, Myeloma & The Holidays

By IMF Admin on August 22, 2011 1:03 PM | No Comments
Living Well with Myeloma Teleconference - Hope, Stress, Myeloma & The Holidays

German Translation for Consolidation Therapy video

By IMF Admin on August 22, 2011 1:03 PM | No Comments
German Translation for Consolidation Therapy video

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Licht - The molecular biology of the MMSET protein of t(4-14) Myeloma

By IMF Admin on August 22, 2011 1:03 PM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Licht - The molecular biology of the MMSET protein of t(4-14) Myeloma

German Translation of The Effect of Genetically Modified Measles....

By IMF Admin on August 22, 2011 1:03 PM | No Comments
German Translation of The Effect of Genetically Modified Measles....

International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Licht - The molecular biology of the MMSET protein of t(4-14) Myeloma

By IMF Admin on August 22, 2011 1:03 PM | No Comments
International Myeloma Workshop 2011
HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT
Dr. Licht - The molecular biology of the MMSET protein of t(4-14) Myeloma

Dr. Dimopoulos - Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study

By IMF Admin on August 22, 2011 12:34 PM | No Comments
Dr. Dimopoulos - Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study

ASCO 2009: Palumbo: A phase III study of VMPT versus VMP in newly diagnosed elderly myeloma patients.

By IMF Admin on August 22, 2011 12:33 PM | No Comments
ASCO 2009: Palumbo: A phase III study of VMPT versus VMP in newly diagnosed elderly myeloma patients.

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Libby - Declining myeloma mortality rates in the United States following introduction of novel therapies

By IMF Admin on August 22, 2011 11:57 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Libby - Declining myeloma mortality rates in the United States following introduction of novel therapies

First Myeloma-Specific Cancer Patient DNA Bank Becomes a Reality

By IMF Admin on August 22, 2011 11:49 AM | No Comments
First Myeloma-Specific Cancer Patient DNA Bank Becomes a Reality

Multiple Myeloma Quilt of Courage #5 - In Memory of Jim Potter

By IMF Admin on August 22, 2011 11:49 AM | No Comments
Multiple Myeloma Quilt of Courage #5 - In Memory of Jim Potter

Myelom Merkur - Juni 2009

By IMF Admin on August 22, 2011 11:48 AM | No Comments
Myelom Merkur - Juni 2009

IMF 2002 Research Grant Awards

By IMF Admin on August 22, 2011 11:12 AM | No Comments
IMF 2002 Research Grant Awards

Dr. Siegel - Results of PX-171-003-A1, An Open-Label, Single-Arm, Phase 2 (Ph 2) Study of Carfilzomib (CFZ) In Patients (pts) with Relapsed and Refractory Multiple Myeloma (MM)

By IMF Admin on August 22, 2011 10:57 AM | No Comments
Dr. Siegel - Results of PX-171-003-A1, An Open-Label, Single-Arm, Phase 2 (Ph 2) Study of Carfilzomib (CFZ) In Patients (pts) with Relapsed and Refractory Multiple Myeloma (MM)

International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Spencer - Pre-clinical Evaluation and Identification of Novel Therapeutics

By IMF Admin on August 22, 2011 10:47 AM | No Comments
International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Spencer - Pre-clinical Evaluation and Identification of Novel Therapeutics

ASCO 2009 - Knop: Bortezomib, IV cyclophosphamide, and dexamethasone (VelCD) as induction therapy in newly diagnosed multiple myeloma: Results of an interim analysis of the German DSMM Xia trial.

By IMF Admin on August 22, 2011 10:41 AM | No Comments
ASCO 2009 - Knop: Bortezomib, IV cyclophosphamide, and dexamethasone (VelCD) as induction therapy in newly diagnosed multiple myeloma: Results of an interim analysis of the German DSMM Xia trial.

Step 1: Know What You're Dealing With: Get the Correct Diagnosis

By IMF Admin on August 22, 2011 8:51 AM | 1 Comment
Step 1: Know What You're Dealing With: Get the Correct Diagnosis

Role of FISH in Myeloma Risk Stratification

By IMF Admin on August 22, 2011 8:26 AM | No Comments
Role of FISH in Myeloma Risk Stratification

Myeloma Quilt of Courage #5 - To Honor All Those on the ACOR Myeloma Listserv

By IMF Admin on August 22, 2011 8:19 AM | No Comments
Myeloma Quilt of Courage #5 - To Honor All Those on the ACOR Myeloma Listserv

International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Weber - Report from US Intergroup

By IMF Admin on August 22, 2011 7:22 AM | No Comments
International Myeloma Workshop 2011
MYELOMA >65 YEARS NEWLY DIAGNOSED: FACTS & QUESTIONS
Dr. Weber - Report from US Intergroup

International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Ocio - Histone Deacetylase Inhibitors

By IMF Admin on August 22, 2011 7:21 AM | No Comments
International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Ocio - Histone Deacetylase Inhibitors

Dr. Abildgaard - Updates from Haematological Research Unit at University of Southern Denmark

By IMF Admin on August 22, 2011 6:59 AM | No Comments
Dr. Abildgaard - Updates from Haematological Research Unit at University of Southern Denmark

International Myeloma Workshop 2011
Dr.Lonial - DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM? SESSION SUMMARY

By IMF Admin on August 22, 2011 6:45 AM | No Comments
International Myeloma Workshop 2011
Dr.Lonial - DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM? SESSION SUMMARY

October 15, 2003 Myeloma Minute

By IMF Admin on August 22, 2011 6:39 AM | No Comments
October 15, 2003 Myeloma Minute

International Myeloma Workshop 2011
Dr. Mateos - NEWLY DIAGNOSED MYELOMA >65 YEARS: FACTS & QUESTIONS SESSION SUMMARY

By IMF Admin on August 22, 2011 6:26 AM | No Comments
International Myeloma Workshop 2011
Dr. Mateos - NEWLY DIAGNOSED MYELOMA >65 YEARS: FACTS & QUESTIONS SESSION SUMMARY

International Myeloma Workshop 2011
Dr. Klein - PLASMA CELL BIOLOGY SESSION SUMMARY

By IMF Admin on August 22, 2011 4:47 AM | No Comments
International Myeloma Workshop 2011
Dr. Klein - PLASMA CELL BIOLOGY SESSION SUMMARY

Sydney 2005:
Welcome

By IMF Admin on August 22, 2011 4:42 AM | No Comments
Sydney 2005:
Welcome

IMF's Multiple Myeloma Quilt of Courage 5

By IMF Admin on August 22, 2011 4:40 AM | No Comments
IMF's Multiple Myeloma Quilt of Courage 5

Treating Multiple Myeloma: The Little Rock Approach

By IMF Admin on August 22, 2011 4:07 AM | No Comments
Treating Multiple Myeloma: The Little Rock Approach

Waldenströms Award Lecture

By IMF Admin on August 22, 2011 4:00 AM | No Comments
Waldenströms Award Lecture

Dr. Vania Hungria

By IMF Admin on August 22, 2011 3:54 AM | 1 Comment
Dr. Vania Hungria

International Myeloma Workshop 2011
Dr.Rajkumar - NEWLY DIAGNOSED MYELOMA >65 YEARS: FACTS & QUESTIONS SESSION SUMMARY

By IMF Admin on August 22, 2011 3:49 AM | No Comments
International Myeloma Workshop 2011
Dr.Rajkumar - NEWLY DIAGNOSED MYELOMA >65 YEARS: FACTS & QUESTIONS SESSION SUMMARY

Sydney 2005: Bone Marrow Microvessel Endothelial Cells in MM Harbor MM-Assoc. Chromosomal Transloc.

By IMF Admin on August 22, 2011 3:19 AM | No Comments
Sydney 2005: Bone Marrow Microvessel Endothelial Cells in MM Harbor MM-Assoc. Chromosomal Transloc.

Interview with Dr. Dimopoulos

By IMF Admin on August 22, 2011 2:44 AM | No Comments
Interview with Dr. Dimopoulos

Myeloma Today Summer 2011

By IMF Admin on August 22, 2011 2:36 AM | No Comments
Myeloma Today Summer 2011

David Hanson

By IMF Admin on August 22, 2011 2:28 AM | No Comments
David Hanson

Sydney 2005:
Update on High Dose Therapy: MAG Studies

By IMF Admin on August 22, 2011 2:17 AM | No Comments
Sydney 2005:
Update on High Dose Therapy: MAG Studies

Myeloma Quilt of Courage #1 - Kathy Backus

By IMF Admin on August 22, 2011 1:45 AM | No Comments
Myeloma Quilt of Courage #1 - Kathy Backus

Introduction

By IMF Admin on August 22, 2011 1:44 AM | No Comments
Introduction

Spotlight on Support: A New Group for Long Island, New York

By IMF Admin on August 22, 2011 1:43 AM | 1 Comment
Spotlight on Support: A New Group for Long Island, New York

Si Tiene Cancer: lo que deber

By IMF Admin on August 22, 2011 12:20 AM | No Comments
Si Tiene Cancer: lo que deber

Dr. Sezer - ASH 2010 G

By IMF Admin on August 22, 2011 12:18 AM | No Comments
Dr. Sezer - ASH 2010 G

????????????? ???? ?????? ? ???????? (????)
?????????? ??? ??????? ??????? ?
5-? ??????????? ??????????? ???? ? ??????

By IMF Admin on August 22, 2011 12:10 AM | No Comments
????????????? ???? ?????? ? ???????? (????)
?????????? ??? ??????? ??????? ?
5-? ??????????? ??????????? ???? ? ??????

About the IMF

By IMF Admin on August 21, 2011 11:44 PM | 1 Comment
About the IMF

Gareth J. Morgan, MD

By IMF Admin on August 21, 2011 11:21 PM | No Comments
Gareth J. Morgan, MD

Myeloma Minute - February 7, 2006

By IMF Admin on August 21, 2011 10:00 PM | No Comments
Myeloma Minute - February 7, 2006

Dr. Tricot - Targeting Myeloma Stem Cells through Simultaneous Inhibition of Wnt and Hedgehog (Hh) Signaling Pathways

By IMF Admin on August 21, 2011 8:27 PM | No Comments
Dr. Tricot - Targeting Myeloma Stem Cells through Simultaneous Inhibition of Wnt and Hedgehog (Hh) Signaling Pathways

Using Kinase Directed SiRNA Screen to Study Signaling Cascade in Development of Drug Resistance

By IMF Admin on August 21, 2011 7:21 PM | No Comments
Using Kinase Directed SiRNA Screen to Study Signaling Cascade in Development of Drug Resistance

Migration and Homing in Multiple Myeloma

By IMF Admin on August 21, 2011 7:18 PM | No Comments
Migration and Homing in Multiple Myeloma

Myeloma Quilt of Courage #5 - For Stanley Sablock

By IMF Admin on August 21, 2011 7:10 PM | No Comments
Myeloma Quilt of Courage #5 - For Stanley Sablock

A Phase I, Multi-Dose Study of SGN-40 (anti-huCD40 mAb) in Patients with MM

By IMF Admin on August 21, 2011 7:08 PM | No Comments
A Phase I, Multi-Dose Study of SGN-40 (anti-huCD40 mAb) in Patients with MM

Targeting NFkB Signaling in Myeloma

By IMF Admin on August 21, 2011 6:58 PM | No Comments
Targeting NFkB Signaling in Myeloma

Myeloma Minute - October 17, 2004

By IMF Admin on August 21, 2011 6:56 PM | No Comments
Myeloma Minute - October 17, 2004

Sydney 2005: DNA Vaccination Against Myeloma Post Autologous or Allogeneic Transplantation

By IMF Admin on August 21, 2011 6:56 PM | No Comments
Sydney 2005: DNA Vaccination Against Myeloma Post Autologous or Allogeneic Transplantation

Therapy Should be Based on Risk Stratification - Against

By IMF Admin on August 21, 2011 6:56 PM | No Comments
Therapy Should be Based on Risk Stratification - Against

Advocacy 101

By IMF Admin on August 21, 2011 6:55 PM | No Comments
Advocacy 101

Simultaneous use of Novel Agents in Induction Therapy

By IMF Admin on August 21, 2011 6:52 PM | No Comments
Simultaneous use of Novel Agents in Induction Therapy

Special Jewelry Discounts for IMF Members

By IMF Admin on August 21, 2011 6:51 PM | No Comments
Special Jewelry Discounts for IMF Members

Myeloma Quilt of Courage #4 - Irene Anderson

By IMF Admin on August 21, 2011 6:34 PM | No Comments
Myeloma Quilt of Courage #4 - Irene Anderson

What's New In Research - February 14, 2003

By IMF Admin on August 21, 2011 6:33 PM | No Comments
What's New In Research - February 14, 2003

A Phase I Study of Novel Proteasome Inhibitor PR-171 (carfilzomib)

By IMF Admin on August 21, 2011 6:32 PM | No Comments
A Phase I Study of Novel Proteasome Inhibitor PR-171 (carfilzomib)

Initial Detection and Diagnosis

By IMF Admin on August 21, 2011 6:31 PM | No Comments
Initial Detection and Diagnosis

Sundar Jagannath, MD, St. Vincents Comprehensive Cancer Center, New York, NY

By IMF Admin on August 21, 2011 6:19 PM | No Comments
Sundar Jagannath, MD, St. Vincents Comprehensive Cancer Center, New York, NY

Ein

By IMF Admin on August 21, 2011 6:15 PM | No Comments
Ein

Myeloma Quilt of Courage #2 - Doyle M. Garrett

By IMF Admin on August 21, 2011 6:14 PM | No Comments
Myeloma Quilt of Courage #2 - Doyle M. Garrett

Myeloma Quilt of Courage #2 - Mom

By IMF Admin on August 21, 2011 6:14 PM | No Comments
Myeloma Quilt of Courage #2 - Mom

Myeloma Awareness Month 2010
Education

By IMF Admin on August 21, 2011 6:06 PM | No Comments
Myeloma Awareness Month 2010
Education

Peter Coulthurst

By IMF Admin on August 21, 2011 6:05 PM | No Comments
Peter Coulthurst

Webcast of Dr. Hartmut Goldschmidt at ASH 2005

By IMF Admin on August 21, 2011 5:54 PM | No Comments
Webcast of Dr. Hartmut Goldschmidt at ASH 2005

MULTİPL MİYELOM

By IMF Admin on August 21, 2011 5:47 PM | No Comments
MULTİPL MİYELOM

Peter Tischler

By IMF Admin on August 21, 2011 5:46 PM | No Comments
Peter Tischler

An Olympic Light Shines on Myeloma

By IMF Admin on August 21, 2011 5:44 PM | No Comments
An Olympic Light Shines on Myeloma

What's New In Research - January 15, 2003

By IMF Admin on August 21, 2011 5:40 PM | No Comments
What's New In Research - January 15, 2003

Treatment Modalities and Symptom Management

By IMF Admin on August 21, 2011 5:27 PM | No Comments
Treatment Modalities and Symptom Management

MYELOMA MINUTE SPECIAL UPDATE:
THALIDOMIDE TO BE COVERED IN MEDICARE DEMONSTRATION PROJECT

By IMF Admin on August 21, 2011 5:26 PM | No Comments
MYELOMA MINUTE SPECIAL UPDATE:
THALIDOMIDE TO BE COVERED IN MEDICARE DEMONSTRATION PROJECT

Anonymous #1

By IMF Admin on August 21, 2011 5:24 PM | No Comments
Anonymous #1

Myeloma Quilt of Courage #2 - Eva Mathisen

By IMF Admin on August 21, 2011 5:19 PM | No Comments
Myeloma Quilt of Courage #2 - Eva Mathisen

By IMF Admin on August 21, 2011 5:17 PM | No Comments

Dex/Thal as Induction and Maintenance Treatment in Elderly Patients with MM : a Randomized Trial

By IMF Admin on August 21, 2011 5:13 PM | No Comments
Dex/Thal as Induction and Maintenance Treatment in Elderly Patients with MM : a Randomized Trial

Myeloma Quilt of Courage #1 - Claire Landers

By IMF Admin on August 21, 2011 5:02 PM | No Comments
Myeloma Quilt of Courage #1 - Claire Landers

Step 1: MGUS

By IMF Admin on August 21, 2011 4:59 PM | No Comments
Step 1: MGUS

ACTION ALERT! Congress Can?t Agree on Spending Bill.

By IMF Admin on August 21, 2011 4:58 PM | No Comments
ACTION ALERT! Congress Can?t Agree on Spending Bill.

Sydney 2005: Phase I Study of Velcade with Revlimid in Relapsed and Refractory MM: The RevVel Study

By IMF Admin on August 21, 2011 4:55 PM | No Comments
Sydney 2005: Phase I Study of Velcade with Revlimid in Relapsed and Refractory MM: The RevVel Study

Myeloma Quilt of Courage #4 - Just Jax

By IMF Admin on August 21, 2011 4:55 PM | No Comments
Myeloma Quilt of Courage #4 - Just Jax

IMWG Consensus Statement Regarding the Current Status of Allogeneic Stem Cell Transplantation for Multiple Myeloma

By IMF Admin on August 21, 2011 4:41 PM | 1 Comment
IMWG Consensus Statement Regarding the Current Status of Allogeneic Stem Cell Transplantation for Multiple Myeloma

January 3, 2002: IMF Myeloma Minute

By IMF Admin on August 21, 2011 4:36 PM | No Comments
January 3, 2002: IMF Myeloma Minute

Myelom Merkur - Ausgabe, August 2006

By IMF Admin on August 21, 2011 4:36 PM | No Comments
Myelom Merkur - Ausgabe, August 2006

IMF 11th Anniversary Gala

By IMF Admin on August 21, 2011 4:34 PM | No Comments
IMF 11th Anniversary Gala

Myeloma Awareness Month 2009
International Myeloma Workshop 2009 Update: Nurse Perspective

By IMF Admin on August 21, 2011 4:32 PM | No Comments
Myeloma Awareness Month 2009
International Myeloma Workshop 2009 Update: Nurse Perspective

What A Difference A Year Makes

By IMF Admin on August 21, 2011 3:29 PM | No Comments
What A Difference A Year Makes

International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Sanderson - Heparanase and Syndecan-1: Promoters of Aggressive Myeloma Behaviour and Targets for Therapy

By IMF Admin on August 21, 2011 3:17 PM | No Comments
International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Sanderson - Heparanase and Syndecan-1: Promoters of Aggressive Myeloma Behaviour and Targets for Therapy

Myeloma Today Summer 2010

By IMF Admin on August 21, 2011 2:39 PM | No Comments
Myeloma Today Summer 2010

Sydney 2005:
New Therapeutic Approaches in Myeloma Bone Disease

By IMF Admin on August 21, 2011 2:10 PM | No Comments
Sydney 2005:
New Therapeutic Approaches in Myeloma Bone Disease

Fiesta for a Cure! - Silent Auction Items

By IMF Admin on August 21, 2011 2:10 PM | No Comments
Fiesta for a Cure! - Silent Auction Items

NEW APPROACHES TO MYELOMA STAGING AND FRONT-LINE TREATMENT SELECTION

By IMF Admin on August 21, 2011 2:10 PM | No Comments
NEW APPROACHES TO MYELOMA STAGING AND FRONT-LINE TREATMENT SELECTION

THAL + DEX IS EFFECTIVE SALVAGE REGIMEN FOR PTS RELAPSING AFTER AUTOLOGOUS TRANSPLANT

By IMF Admin on August 21, 2011 2:09 PM | No Comments
THAL + DEX IS EFFECTIVE SALVAGE REGIMEN FOR PTS RELAPSING AFTER AUTOLOGOUS TRANSPLANT

Sydney 2005: The Role of Dendritic Cell Genotype in the Induction of T-Cell Responses...

By IMF Admin on August 21, 2011 2:08 PM | No Comments
Sydney 2005: The Role of Dendritic Cell Genotype in the Induction of T-Cell Responses...

Spotlight on MUSIC AGAINST MYELOMA

By IMF Admin on August 21, 2011 1:58 PM | No Comments
Spotlight on MUSIC AGAINST MYELOMA

Important New Blood Cancer Initiative Announced on Capitol Hill

By IMF Admin on August 21, 2011 1:41 PM | No Comments
Important New Blood Cancer Initiative Announced on Capitol Hill

Steven Howell

By IMF Admin on August 21, 2011 1:40 PM | No Comments
Steven Howell

Bone Metabolism, Bone Disease, and the Bisphosphonates

By IMF Admin on August 21, 2011 1:36 PM | No Comments
Bone Metabolism, Bone Disease, and the Bisphosphonates

Myeloma Quilt of Courage #4 - Kathleen McBain

By IMF Admin on August 21, 2011 1:27 PM | No Comments
Myeloma Quilt of Courage #4 - Kathleen McBain

Dr. Harousseau - ASH 2008 - Velcade-Dexamethasone versus VAD as Induction Treatment Prior to ASCT in Newly Diagnosed MM. Updated Results of the IFM2005/01 Trial.

By IMF Admin on August 21, 2011 1:01 PM | No Comments
Dr. Harousseau - ASH 2008 - Velcade-Dexamethasone versus VAD as Induction Treatment Prior to ASCT in Newly Diagnosed MM. Updated Results of the IFM2005/01 Trial.

May 21, 2002: IMF Myeloma Minute

By IMF Admin on August 21, 2011 12:53 PM | No Comments
May 21, 2002: IMF Myeloma Minute

Advocacy Update - November 15, 2010

By IMF Admin on August 21, 2011 12:49 PM | No Comments
Advocacy Update - November 15, 2010

Thalidomide: Clinical Outcomes

By IMF Admin on August 21, 2011 12:41 PM | No Comments
Thalidomide: Clinical Outcomes

WAITING

By IMF Admin on August 21, 2011 12:41 PM | No Comments
WAITING

My New First Birthday

By IMF Admin on August 21, 2011 12:40 PM | No Comments
My New First Birthday

New for 2009! IMF Holiday Cards

By IMF Admin on August 21, 2011 12:22 PM | 2 Comments
New for 2009! IMF Holiday Cards

Conversations at ASCO 2008:
Antonio Palumbo, MD
University of Torino and Italian Multiple Myeloma Study Group

By IMF Admin on August 21, 2011 12:08 PM | No Comments
Conversations at ASCO 2008:
Antonio Palumbo, MD
University of Torino and Italian Multiple Myeloma Study Group

Pictures from the San Jose Patient and Family Seminar
July 16-17, 2004

By IMF Admin on August 21, 2011 12:07 PM | No Comments
Pictures from the San Jose Patient and Family Seminar
July 16-17, 2004

QUARTERLY UPDATE FROM BANK ON A CURE

By IMF Admin on August 21, 2011 12:06 PM | No Comments
QUARTERLY UPDATE FROM BANK ON A CURE

Sydney 2005:
Final Results of IFM9904 Protocol: Dbl. Transplant +/- anti-IL6 Mono. Antibody in..

By IMF Admin on August 21, 2011 12:04 PM | No Comments
Sydney 2005:
Final Results of IFM9904 Protocol: Dbl. Transplant +/- anti-IL6 Mono. Antibody in..

Open Thalomid (thalidomide) Clinical Trials

By IMF Admin on August 21, 2011 12:03 PM | No Comments
Open Thalomid (thalidomide) Clinical Trials

Daily Update from International Myeloma Workshop - April 13, 2005

By IMF Admin on August 21, 2011 11:54 AM | No Comments
Daily Update from International Myeloma Workshop - April 13, 2005

REPORT FROM AMEN'S SECOND ANNIVERSARY

By IMF Admin on August 21, 2011 11:48 AM | No Comments
REPORT FROM AMEN'S SECOND ANNIVERSARY

Sydney 2005: In Vitro Activity of a Novel Small Molecule Cyclin Dependent Kinase inhibitor, CYC202..

By IMF Admin on August 21, 2011 11:45 AM | No Comments
Sydney 2005: In Vitro Activity of a Novel Small Molecule Cyclin Dependent Kinase inhibitor, CYC202..

Antonio Palumbo, MD, of The Italian Multiple Myeloma Study Group

By IMF Admin on August 21, 2011 11:44 AM | No Comments
Antonio Palumbo, MD, of The Italian Multiple Myeloma Study Group

October 16, 2001 Myeloma Minute

By IMF Admin on August 21, 2011 11:43 AM | No Comments
October 16, 2001 Myeloma Minute

Myeloma Minute - November 28, 2004

By IMF Admin on August 21, 2011 11:38 AM | No Comments
Myeloma Minute - November 28, 2004

συνέντευξη - Dr. Meletios-Athanassios Dimopoulos

By IMF Admin on August 21, 2011 11:37 AM | No Comments
συνέντευξη - Dr. Meletios-Athanassios Dimopoulos

Myeloma Quilt of Courage #1 - Trudy Fobbs

By IMF Admin on August 21, 2011 11:34 AM | No Comments
Myeloma Quilt of Courage #1 - Trudy Fobbs

Dr. Dimopoulos - Upfront Treatment with Novel Agents Improves the Survival of Symptomatic Patients with Multiple Myeloma Who Are Older Than 65 Years

By IMF Admin on August 21, 2011 11:16 AM | No Comments
Dr. Dimopoulos - Upfront Treatment with Novel Agents Improves the Survival of Symptomatic Patients with Multiple Myeloma Who Are Older Than 65 Years

ASH 2005 Webcast - SNP Analysis Of Transplant Patients

By IMF Admin on August 21, 2011 11:16 AM | No Comments
ASH 2005 Webcast - SNP Analysis Of Transplant Patients

Myeloma Minute - October 26, 2004

By IMF Admin on August 21, 2011 11:00 AM | No Comments
Myeloma Minute - October 26, 2004

Team Milers Against Myeloma
San Diego Rock ?n Roll Marathon

By IMF Admin on August 21, 2011 10:58 AM | No Comments
Team Milers Against Myeloma
San Diego Rock ?n Roll Marathon

Special Myeloma Minute: Medicare eligible? Apply NOW to save 90% of thalidomide costs!

By IMF Admin on August 21, 2011 10:58 AM | No Comments
Special Myeloma Minute: Medicare eligible? Apply NOW to save 90% of thalidomide costs!

DANIEL EGIL BERGSAGEL, CM, MD, D.Phil
April 25, 1925 ? October 20, 2007

By IMF Admin on August 21, 2011 10:57 AM | No Comments
DANIEL EGIL BERGSAGEL, CM, MD, D.Phil
April 25, 1925 ? October 20, 2007

Sydney 2005:
Cell Cycle Control of Multiple Myeloma Pathogenesis

By IMF Admin on August 21, 2011 10:56 AM | No Comments
Sydney 2005:
Cell Cycle Control of Multiple Myeloma Pathogenesis

Myeloma Minute - March 21, 2006

By IMF Admin on August 21, 2011 10:52 AM | No Comments
Myeloma Minute - March 21, 2006

Clin. implications of t(11;14)(q13;q32), t(4;14)(p16;q32) and -17p13 (p53) deletions in pts with HDT

By IMF Admin on August 21, 2011 10:51 AM | No Comments
Clin. implications of t(11;14)(q13;q32), t(4;14)(p16;q32) and -17p13 (p53) deletions in pts with HDT

Disease Control with active Long-Term Treatment

By IMF Admin on August 21, 2011 10:48 AM | No Comments
Disease Control with active Long-Term Treatment

What's New In Research - February 26, 2003

By IMF Admin on August 21, 2011 10:47 AM | No Comments
What's New In Research - February 26, 2003

Comedy Celebration 2009 Tickets & Pricing

By IMF Admin on August 21, 2011 10:45 AM | No Comments
Comedy Celebration 2009 Tickets & Pricing

International Myeloma Workshop 2011
Dr. Morgan - HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT SESSION SUMMARY

By IMF Admin on August 21, 2011 10:36 AM | No Comments
International Myeloma Workshop 2011
Dr. Morgan - HIGH-RISK ENTITIES OF MYELOMA: FROM BIOLOGY TO TREATMENT SESSION SUMMARY

16th Anniversary Gala Sponsors

By IMF Admin on August 21, 2011 10:33 AM | No Comments
16th Anniversary Gala Sponsors

Myeloma Quilt of Courage #4 - In Loving Memory

By IMF Admin on August 21, 2011 10:32 AM | No Comments
Myeloma Quilt of Courage #4 - In Loving Memory

Sydney 2005:
Role of the IGF-1/IGF-1 Receptor Pathway in the 5TMM Experimental Mouse Model

By IMF Admin on August 21, 2011 10:30 AM | No Comments
Sydney 2005:
Role of the IGF-1/IGF-1 Receptor Pathway in the 5TMM Experimental Mouse Model

Myeloma Quilt of Courage #3 - Jeanne Bechtel

By IMF Admin on August 21, 2011 10:30 AM | No Comments
Myeloma Quilt of Courage #3 - Jeanne Bechtel

ASH 2009 Highlights for Patients with Myeloma

By IMF Admin on August 21, 2011 10:25 AM | No Comments
ASH 2009 Highlights for Patients with Myeloma

Dr. Gertz - Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

By IMF Admin on August 21, 2011 10:13 AM | No Comments
Dr. Gertz - Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Hutchison - Myeloma Cast Nephropathy

By IMF Admin on August 21, 2011 10:07 AM | No Comments
International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Hutchison - Myeloma Cast Nephropathy

Thank you for your support of the Myeloma Survivor!

By IMF Admin on August 21, 2011 10:06 AM | No Comments
Thank you for your support of the Myeloma Survivor!

A. Palumbo, MD, The Italian Multilple Myeloma Study Group

By IMF Admin on August 21, 2011 10:05 AM | No Comments
A. Palumbo, MD, The Italian Multilple Myeloma Study Group

2005 Brian D. Novis Grant Winners

By IMF Admin on August 21, 2011 9:58 AM | No Comments
2005 Brian D. Novis Grant Winners

Message from IMF President

By IMF Admin on August 21, 2011 9:58 AM | No Comments
Message from IMF President

Mario Boccadoro, MD

By IMF Admin on August 21, 2011 9:58 AM | No Comments
Mario Boccadoro, MD

IMF's Multiple Myeloma Quilt of Courage 1

By IMF Admin on August 21, 2011 9:58 AM | No Comments
IMF's Multiple Myeloma Quilt of Courage 1

Dr. Drach - ASH 2008 - Ein

By IMF Admin on August 21, 2011 9:58 AM | No Comments
Dr. Drach - ASH 2008 - Ein

Dr. Salwender - ASH 2008 - Ein

By IMF Admin on August 21, 2011 9:58 AM | No Comments
Dr. Salwender - ASH 2008 - Ein

Sydney 2005: The Transcriptome of MM Defines Disease Subgrps w/ Distinct Genetic & Clinical Features

By IMF Admin on August 21, 2011 9:58 AM | No Comments
Sydney 2005: The Transcriptome of MM Defines Disease Subgrps w/ Distinct Genetic & Clinical Features

The IMF Welcomes Our International Partners

By IMF Admin on August 21, 2011 9:58 AM | No Comments
The IMF Welcomes Our International Partners

Report from the 2nd Annual Czech Myeloma Group Patient Seminar

By IMF Admin on August 21, 2011 9:58 AM | No Comments
Report from the 2nd Annual Czech Myeloma Group Patient Seminar

Myeloma Quilt of Courage #1 - Cathy Margelewski

By IMF Admin on August 21, 2011 9:46 AM | No Comments
Myeloma Quilt of Courage #1 - Cathy Margelewski

Myeloma Quilt of Courage #3 - Anne Heutlinger

By IMF Admin on August 21, 2011 9:45 AM | No Comments
Myeloma Quilt of Courage #3 - Anne Heutlinger

Consensus Panel Session Introduction

By IMF Admin on August 21, 2011 9:45 AM | No Comments
Consensus Panel Session Introduction

Programs & Meetings

By IMF Admin on August 21, 2011 9:45 AM | No Comments
Programs & Meetings

Autologous Bone Marrow and Stem Cell Transplantation For Multiple Myeloma, part 2

By IMF Admin on August 21, 2011 9:42 AM | No Comments
Autologous Bone Marrow and Stem Cell Transplantation For Multiple Myeloma, part 2

Report from the Third Anniversary of AMEN

By IMF Admin on August 21, 2011 9:41 AM | No Comments
Report from the Third Anniversary of AMEN

An IMF Myeloma Minute Special Report

By IMF Admin on August 21, 2011 9:37 AM | No Comments
An IMF Myeloma Minute Special Report

Timing of Transplant in the Era of New Drugs

By IMF Admin on August 21, 2011 9:36 AM | No Comments
Timing of Transplant in the Era of New Drugs

Myeloma Quilt of Courage #3 - Laura Schultz

By IMF Admin on August 21, 2011 9:36 AM | No Comments
Myeloma Quilt of Courage #3 - Laura Schultz

Michio M. Kawano, MD

By IMF Admin on August 21, 2011 9:31 AM | No Comments
Michio M. Kawano, MD

test

By IMF Admin on August 21, 2011 9:24 AM | No Comments
test

Sandra Smith

By IMF Admin on August 21, 2011 9:22 AM | No Comments
Sandra Smith

Myeloma Quilt of Courage #2 - William V. Herbert

By IMF Admin on August 21, 2011 9:21 AM | No Comments
Myeloma Quilt of Courage #2 - William V. Herbert

Morton Coleman, MD, Weill Medical College, Cornell University, New York, NY

By IMF Admin on August 21, 2011 9:03 AM | No Comments
Morton Coleman, MD, Weill Medical College, Cornell University, New York, NY

Dr. Knop - Ein

By IMF Admin on August 21, 2011 8:53 AM | No Comments
Dr. Knop - Ein

THE INTERNATIONAL MYELOMA FOUNDATION IDENTIFIES POTENTIAL LINK BETWEEN GENETIC PATHWAYS AND ENVIRONMENTAL RISKS FOR MYELOMA

By IMF Admin on August 21, 2011 8:52 AM | No Comments
THE INTERNATIONAL MYELOMA FOUNDATION IDENTIFIES POTENTIAL LINK BETWEEN GENETIC PATHWAYS AND ENVIRONMENTAL RISKS FOR MYELOMA

Myeloma MInute - August 18,2007

By IMF Admin on August 21, 2011 8:46 AM | No Comments
Myeloma MInute - August 18,2007

IMF Receives Grant from Goldman Philanthropic Foundation for Bank On A Cure®

By IMF Admin on August 21, 2011 8:42 AM | No Comments
IMF Receives Grant from Goldman Philanthropic Foundation for Bank On A Cure®

OSTEONECROSIS OF THE JAWS IN MYELOMA:
Time Dependent Correlation with AREDIA and ZOMETA Use

By IMF Admin on August 21, 2011 8:42 AM | No Comments
OSTEONECROSIS OF THE JAWS IN MYELOMA:
Time Dependent Correlation with AREDIA and ZOMETA Use

STEP 6: RESPONSE ASSESSMENT - IS TREATMENT WORKING?

By IMF Admin on August 21, 2011 8:41 AM | No Comments
STEP 6: RESPONSE ASSESSMENT - IS TREATMENT WORKING?

FDA Approves Aredia For The Treatment Of Myeloma Bone Disease

By IMF Admin on August 21, 2011 8:41 AM | No Comments
FDA Approves Aredia For The Treatment Of Myeloma Bone Disease

What YOU Can DO

By IMF Admin on August 21, 2011 8:40 AM | No Comments
What YOU Can DO

Charlotte Longo

By IMF Admin on August 21, 2011 8:40 AM | No Comments
Charlotte Longo

Myeloma Quilt of Courage #3 - Patricia Wascher

By IMF Admin on August 21, 2011 8:40 AM | No Comments
Myeloma Quilt of Courage #3 - Patricia Wascher

Dr. Munshi - ASH 2008 - Alternate Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A High-Density Exon Array Analysis of Uniformly Treated Newly-Diagnosed Myeloma Patients

By IMF Admin on August 21, 2011 8:39 AM | No Comments
Dr. Munshi - ASH 2008 - Alternate Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A High-Density Exon Array Analysis of Uniformly Treated Newly-Diagnosed Myeloma Patients

Ask the Expert

By IMF Admin on August 21, 2011 8:38 AM | No Comments
Ask the Expert

Dr. Zonder - ASH 2008 - Phase I Study of Elotuzumab (HuLuc63) in Phase I Study of Elotuzumab (HuLuc63) in Relapsed/Refractory Multiple Myeloma

By IMF Admin on August 21, 2011 8:35 AM | No Comments
Dr. Zonder - ASH 2008 - Phase I Study of Elotuzumab (HuLuc63) in Phase I Study of Elotuzumab (HuLuc63) in Relapsed/Refractory Multiple Myeloma

Post Transplant Maintenance

By IMF Admin on August 21, 2011 8:34 AM | No Comments
Post Transplant Maintenance

IMF NAMES 2010 ROBERT A. KYLE LIFETIME ACHIEVEMENT AWARD RECIPIENT PROF. JOAN BLADÉ

By IMF Admin on August 21, 2011 8:30 AM | No Comments
IMF NAMES 2010 ROBERT A. KYLE LIFETIME ACHIEVEMENT AWARD RECIPIENT PROF. JOAN BLADÉ

Myeloma Minute - February 1, 2006

By IMF Admin on August 21, 2011 8:28 AM | No Comments
Myeloma Minute - February 1, 2006

IMF 2003 Research Grant Awards

By IMF Admin on August 21, 2011 8:18 AM | No Comments
IMF 2003 Research Grant Awards

Media Information for Comedy Celebratiaon 2009

By IMF Admin on August 21, 2011 8:14 AM | No Comments
Media Information for Comedy Celebratiaon 2009

Sydney 2005:
Plasmapheresis in Renal Failure

By IMF Admin on August 21, 2011 8:14 AM | No Comments
Sydney 2005:
Plasmapheresis in Renal Failure

Catherine Kerr

By IMF Admin on August 21, 2011 8:13 AM | No Comments
Catherine Kerr

A.C.E. Levels

By IMF Admin on August 21, 2011 7:54 AM | No Comments
A.C.E. Levels

Myeloma Minute
August 25, 2008

By IMF Admin on August 21, 2011 7:45 AM | No Comments
Myeloma Minute
August 25, 2008

Myeloma Minute Subscription Issues

By IMF Admin on August 21, 2011 7:45 AM | No Comments
Myeloma Minute Subscription Issues

Multiple Myeloma Group In France

By IMF Admin on August 21, 2011 7:44 AM | No Comments
Multiple Myeloma Group In France

International Myeloma Workshop 2011
Dr.Palumbo - NEWLY DIAGNOSED MYELOMA>65 YEARS: FACTS & QUESTIONS SESSION SUMMARY

By IMF Admin on August 21, 2011 7:28 AM | No Comments
International Myeloma Workshop 2011
Dr.Palumbo - NEWLY DIAGNOSED MYELOMA>65 YEARS: FACTS & QUESTIONS SESSION SUMMARY

Calling All Kids: Youth Artists Wanted!
Help Design the IMF's Holiday Greeting Cards

By IMF Admin on August 21, 2011 7:19 AM | No Comments
Calling All Kids: Youth Artists Wanted!
Help Design the IMF's Holiday Greeting Cards

Statins In Myeloma

By IMF Admin on August 21, 2011 7:19 AM | No Comments
Statins In Myeloma

Recent Newspaper Article Highlights the Importance of OVAC Advocacy Day

By IMF Admin on August 21, 2011 7:19 AM | No Comments
Recent Newspaper Article Highlights the Importance of OVAC Advocacy Day

ASH 2005 Webcast - Aplidin For Relapsed/Refractory Myeloma

By IMF Admin on August 21, 2011 7:06 AM | No Comments
ASH 2005 Webcast - Aplidin For Relapsed/Refractory Myeloma

Phase III THALOMID® Clinical Trials

By IMF Admin on August 21, 2011 7:06 AM | No Comments
Phase III THALOMID® Clinical Trials

Myeloma Quilt of Courage #1 - Marcia Sawyer

By IMF Admin on August 21, 2011 7:00 AM | No Comments
Myeloma Quilt of Courage #1 - Marcia Sawyer

The Stafford Family Funds Myeloma Research Grant

By IMF Admin on August 21, 2011 6:58 AM | No Comments
The Stafford Family Funds Myeloma Research Grant

Oral lenalidomide plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma.

By IMF Admin on August 21, 2011 6:58 AM | No Comments
Oral lenalidomide plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma.

Dr. Gertz - ASH 2008 - An Overview of the 50th ASH Annual Meeting and Exposition
December 6-9, 2008 in San Francisco, CA and

By IMF Admin on August 21, 2011 6:58 AM | No Comments
Dr. Gertz - ASH 2008 - An Overview of the 50th ASH Annual Meeting and Exposition
December 6-9, 2008 in San Francisco, CA and

Collette Barkley

By IMF Admin on August 21, 2011 6:57 AM | 1 Comment
Collette Barkley

Medicare and Appropriations Bills Threaten to Leave Most Cancer Patients Behind

By IMF Admin on August 21, 2011 6:51 AM | No Comments
Medicare and Appropriations Bills Threaten to Leave Most Cancer Patients Behind

Rolf Pelzing - European Myeloma Platform (EMP)

By IMF Admin on August 21, 2011 6:40 AM | No Comments
Rolf Pelzing - European Myeloma Platform (EMP)

ASCO 2009 - Shaughnessy: Use of bortezomib (BOR) pharmacogenomics (PG) to identify mechanisms of drug resistance and predict survival in multiple myeloma (MM) treated with total therapy 3 (TT3).

By IMF Admin on August 21, 2011 6:38 AM | No Comments
ASCO 2009 - Shaughnessy: Use of bortezomib (BOR) pharmacogenomics (PG) to identify mechanisms of drug resistance and predict survival in multiple myeloma (MM) treated with total therapy 3 (TT3).

Pennie Lawrence

By IMF Admin on August 21, 2011 6:37 AM | No Comments
Pennie Lawrence

Optimizing Novel Therapies, Sequencing of Agents and Retreatment Options

By IMF Admin on August 21, 2011 6:36 AM | No Comments
Optimizing Novel Therapies, Sequencing of Agents and Retreatment Options

Myelom Merkur - September 2009

By IMF Admin on August 21, 2011 6:36 AM | No Comments
Myelom Merkur - September 2009

Theresa Cornelis

By IMF Admin on August 21, 2011 6:36 AM | No Comments
Theresa Cornelis

Expert Opinions on Multiple Myeloma
Note: This program is in the process of revision.

By IMF Admin on August 21, 2011 6:35 AM | No Comments
Expert Opinions on Multiple Myeloma
Note: This program is in the process of revision.

Dr. Harousseau - ASH 2008 - Superior Outcomes Associated with Complete Response: Analysis of the Phase III VISTA Study of Bortezomib Plus Melphalan?Prednisone Versus Melphalan?Prednisone

By IMF Admin on August 21, 2011 6:33 AM | No Comments
Dr. Harousseau - ASH 2008 - Superior Outcomes Associated with Complete Response: Analysis of the Phase III VISTA Study of Bortezomib Plus Melphalan?Prednisone Versus Melphalan?Prednisone

GLOSSARY OF TERMS & DEFINITIONS

By IMF Admin on August 21, 2011 6:28 AM | 1 Comment
GLOSSARY OF TERMS & DEFINITIONS

ASCO 2009 - Crowley: Prognostic factor analyses of myeloma (MM) survival outcomes on intergroup trial S9321 (int 0141): Examining whether different variables govern different time segments of survival.

By IMF Admin on August 21, 2011 6:24 AM | No Comments
ASCO 2009 - Crowley: Prognostic factor analyses of myeloma (MM) survival outcomes on intergroup trial S9321 (int 0141): Examining whether different variables govern different time segments of survival.

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Siegel - Results of PX-171-003-A1, an open-label, single-arm, phase (PH) 2 study of carfilzomib in patients with relapsed/refractory Multiple Myeloma

By IMF Admin on August 21, 2011 6:22 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Siegel - Results of PX-171-003-A1, an open-label, single-arm, phase (PH) 2 study of carfilzomib in patients with relapsed/refractory Multiple Myeloma

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Zamagni - Prognostic relevance of 18F-FDG PET/CT in newly diagnosed Multiple Myeloma patients receiving up-front autologous stem-cell transplantation (ASCT): a prospective study

By IMF Admin on August 21, 2011 6:21 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION II
Dr. Zamagni - Prognostic relevance of 18F-FDG PET/CT in newly diagnosed Multiple Myeloma patients receiving up-front autologous stem-cell transplantation (ASCT): a prospective study

International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Treon - Update in the Treatment of WM

By IMF Admin on August 21, 2011 6:18 AM | No Comments
International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Treon - Update in the Treatment of WM

International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Dispenzieri - Poems Syndrome

By IMF Admin on August 21, 2011 6:17 AM | No Comments
International Myeloma Workshop 2011
MONOCLONAL IMMUNOGLOBULIN AND THE NERVE, WALDENSTROM'S MACROGLOBULINEMIA
Dr. Dispenzieri - Poems Syndrome

Ralph Ferrizzi Memorial Golf Tournament

By IMF Admin on August 21, 2011 6:16 AM | No Comments
Ralph Ferrizzi Memorial Golf Tournament

Immunomedics Reports on New Humanized Antibody Therapeutics at American Society of Hematology Mtg

By IMF Admin on August 21, 2011 6:14 AM | No Comments
Immunomedics Reports on New Humanized Antibody Therapeutics at American Society of Hematology Mtg

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Panel Discussion

By IMF Admin on August 21, 2011 6:14 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Panel Discussion

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Zhu - Cereblon (CRBN) is a Requirement for the Anti-myeloma Activity of Thalidomide, Lenalidomide and Pomalidomide
Presented by Dr. Keith Stewart

By IMF Admin on August 21, 2011 6:13 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Zhu - Cereblon (CRBN) is a Requirement for the Anti-myeloma Activity of Thalidomide, Lenalidomide and Pomalidomide
Presented by Dr. Keith Stewart

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Sawyer - Jumping Translocations 1Q12 Contribute to Copy Number (CN) variations in Multiple Myeloma: Unexpected CN Gains Involving Duplications and Translocations of Receptor Chro

By IMF Admin on August 21, 2011 6:12 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Sawyer - Jumping Translocations 1Q12 Contribute to Copy Number (CN) variations in Multiple Myeloma: Unexpected CN Gains Involving Duplications and Translocations of Receptor Chromosomes

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Lokhorst - Current Place of Allogeneic Transplantation in Myeloma

By IMF Admin on August 21, 2011 6:10 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Lokhorst - Current Place of Allogeneic Transplantation in Myeloma

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Bae - Multiepitope Vaccine to Treat Patients with Myeloma-related Disease: Potential Clinical Application

By IMF Admin on August 21, 2011 6:09 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Bae - Multiepitope Vaccine to Treat Patients with Myeloma-related Disease: Potential Clinical Application

International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Joshua - Immunotherapy in Myeloma: Myth or Reality?

By IMF Admin on August 21, 2011 6:09 AM | No Comments
International Myeloma Workshop 2011
PLENARY ABSTRACT SESSION I
Dr. Joshua - Immunotherapy in Myeloma: Myth or Reality?

International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Landgren - Risk of Subsequent Primary Malignancies in Patients with Multiple Myeloma Before and After the Introduction of Novel Therapies: A Population-b

By IMF Admin on August 21, 2011 6:07 AM | No Comments
International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Landgren - Risk of Subsequent Primary Malignancies in Patients with Multiple Myeloma Before and After the Introduction of Novel Therapies: A Population-based Study in Sweden

ASCO 2009 - Durie: Highlights

By IMF Admin on August 21, 2011 6:06 AM | No Comments
ASCO 2009 - Durie: Highlights

Thalidomide

By IMF Admin on August 21, 2011 6:04 AM | No Comments
Thalidomide

International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Palumbo - Secondary Malignancies in Elderly Myeloma Patients

By IMF Admin on August 21, 2011 6:03 AM | No Comments
International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Palumbo - Secondary Malignancies in Elderly Myeloma Patients

Sydney 2005:
T Cells in Myeloma: Lessons from a Murine Model

By IMF Admin on August 21, 2011 6:02 AM | No Comments
Sydney 2005:
T Cells in Myeloma: Lessons from a Murine Model

EVALUATION OF THE PATIENT IN INITIAL RELAPSE AND SELECTION OF SECOND-LINE THERAPEUTIC OPTIONS

By IMF Admin on August 21, 2011 6:02 AM | No Comments
EVALUATION OF THE PATIENT IN INITIAL RELAPSE AND SELECTION OF SECOND-LINE THERAPEUTIC OPTIONS

International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. McCarthy - Phase III Intergroup Study of Lenalidomide versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant (ASCT) for Mult

By IMF Admin on August 21, 2011 6:01 AM | No Comments
International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. McCarthy - Phase III Intergroup Study of Lenalidomide versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM): CALGB ECOG BMT-CNT 100104

International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Attal - Maintenance Treatment with Lenalidomide after Transplantation for Myeloma: Analysis of Secondary Malignancies within the IFM 2005-02 Trial

By IMF Admin on August 21, 2011 6:00 AM | No Comments
International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Attal - Maintenance Treatment with Lenalidomide after Transplantation for Myeloma: Analysis of Secondary Malignancies within the IFM 2005-02 Trial

International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Fermand - Introduction

By IMF Admin on August 21, 2011 6:00 AM | No Comments
International Myeloma Workshop 2011
SECONDARY MALIGNANCY IN MYELOMA: AN EMERGING ISSUE?
Dr. Fermand - Introduction

International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Anderson - Introduction Lecture

By IMF Admin on August 21, 2011 5:58 AM | No Comments
International Myeloma Workshop 2011
NEW DRUGS AND THERAPEUTIC APPROACHES
Dr. Anderson - Introduction Lecture

International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Bridoux - Myeloma Cast Nephropathy

By IMF Admin on August 21, 2011 5:57 AM | No Comments
International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Bridoux - Myeloma Cast Nephropathy

International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Merlini - Management of AL amyloidosis in 2011

By IMF Admin on August 21, 2011 5:56 AM | No Comments
International Myeloma Workshop 2011
MYELOMA CAST NEPHROPATHY & AL AMYLOIDOSIS
Dr. Merlini - Management of AL amyloidosis in 2011

STEP 8: KEEPING TRACK OF THE MYELOMA - MONITORING WITHOUT MYSTERY

By IMF Admin on August 21, 2011 5:55 AM | No Comments
STEP 8: KEEPING TRACK OF THE MYELOMA - MONITORING WITHOUT MYSTERY

International Myeloma Workshop 2011
DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM?
Panel Discussion

By IMF Admin on August 21, 2011 5:55 AM | No Comments
International Myeloma Workshop 2011
DEBATE: SHOULD WE TREAT SOME PATIENTS WITH STAGE I MM?
Panel Discussion

International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Morgan - Report from EMNTG-MRC

By IMF Admin on August 21, 2011 5:54 AM | No Comments
International Myeloma Workshop 2011
NEWLY DIAGNOSED MYELOMA <65 YEARS: FACTS & QUESTIONS
Dr. Morgan - Report from EMNTG-MRC

International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Yaccoby - Bone Anabolism and Tumor Growth in Myeloma

By IMF Admin on August 21, 2011 5:50 AM | No Comments
International Myeloma Workshop 2011
BONE DISEASE AND ANIMAL MODELS
Dr. Yaccoby - Bone Anabolism and Tumor Growth in Myeloma

International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Dr. Croce - Introduction Lecture: Physiopathology of Myeloma. What Role for MicroRNAs?

By IMF Admin on August 21, 2011 5:49 AM | No Comments
International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Dr. Croce - Introduction Lecture: Physiopathology of Myeloma. What Role for MicroRNAs?

Myeloma Minute - June 21, 2006

By IMF Admin on August 21, 2011 5:48 AM | No Comments
Myeloma Minute - June 21, 2006

International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Lee - Introduction lecture: "The UPR system"

By IMF Admin on August 21, 2011 5:45 AM | No Comments
International Myeloma Workshop 2011
PLASMA CELL BIOLOGY
Dr. Lee - Introduction lecture: "The UPR system"

Myeloma Minute - September 13, 2006

By IMF Admin on August 21, 2011 5:45 AM | No Comments
Myeloma Minute - September 13, 2006

HOVON-50 Final Analysis of Thalidomide Combined with Adriamycine, Dexamethasone and HDM

By IMF Admin on August 21, 2011 5:44 AM | No Comments
HOVON-50 Final Analysis of Thalidomide Combined with Adriamycine, Dexamethasone and HDM

International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Dr. Minvielle - The Genetic Progression of Myeloma

By IMF Admin on August 21, 2011 5:43 AM | No Comments
International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Dr. Minvielle - The Genetic Progression of Myeloma

International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Dr. Fonseca - The Different Subtypes of Myeloma

By IMF Admin on August 21, 2011 5:42 AM | No Comments
International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Dr. Fonseca - The Different Subtypes of Myeloma

International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Panel Discussion

By IMF Admin on August 21, 2011 5:41 AM | No Comments
International Myeloma Workshop 2011
MOLECULAR PATHWAYS/GENETICS
Panel Discussion

Maintenance Therapy

By IMF Admin on August 21, 2011 5:40 AM | No Comments
Maintenance Therapy

Consensus on Care:Updates in the Management of Side Effects in Multiple Myeloma: A Case-Based Approach to Care

By IMF Admin on August 21, 2011 5:40 AM | No Comments
Consensus on Care:Updates in the Management of Side Effects in Multiple Myeloma: A Case-Based Approach to Care

Funding and Medicare Issues Still Debated by Congress

By IMF Admin on August 21, 2011 5:40 AM | No Comments
Funding and Medicare Issues Still Debated by Congress

Complications Associated With This Disease

By IMF Admin on August 21, 2011 5:39 AM | No Comments
Complications Associated With This Disease

Case Studies in the Management of Venous Thromboembolic Events and Peripheral Neuropathy in Multiple Myeloma

By IMF Admin on August 21, 2011 5:38 AM | No Comments
Case Studies in the Management of Venous Thromboembolic Events and Peripheral Neuropathy in Multiple Myeloma

THE INTERNATIONAL MYELOMA FOUNDATION SAYS MOZOBIL? APPROVAL COULD BENEFIT MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTS

By IMF Admin on August 21, 2011 5:32 AM | No Comments
THE INTERNATIONAL MYELOMA FOUNDATION SAYS MOZOBIL? APPROVAL COULD BENEFIT MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTS

Future Perspectives in Myeloma Management

By IMF Admin on August 21, 2011 5:29 AM | No Comments
Future Perspectives in Myeloma Management

Phase I evaluation of carfilzomib (PR-171) in hematological malignancies: Responses in multiple myeloma and Waldenstrom's macroglobulinemia at well-tolerated doses.

By IMF Admin on August 21, 2011 5:29 AM | No Comments
Phase I evaluation of carfilzomib (PR-171) in hematological malignancies: Responses in multiple myeloma and Waldenstrom's macroglobulinemia at well-tolerated doses.

David's 20th Anniversary Message

By IMF Admin on August 21, 2011 5:28 AM | No Comments
David's 20th Anniversary Message

Impact of Myeloma Disease, Treatments, Long-Term Effects, and Patient-Specific Characteristics on Renal Complications, Sexuality and Sexual Dysfunction

By IMF Admin on August 21, 2011 5:27 AM | No Comments
Impact of Myeloma Disease, Treatments, Long-Term Effects, and Patient-Specific Characteristics on Renal Complications, Sexuality and Sexual Dysfunction

THE CATLETT CARD SERIES

By IMF Admin on August 21, 2011 5:25 AM | No Comments
THE CATLETT CARD SERIES

The F.O.R. (Friends of Richie) Benefit Story

By IMF Admin on August 21, 2011 5:24 AM | No Comments
The F.O.R. (Friends of Richie) Benefit Story

You are now leaving the IMF website and are accessing the Ortho Biotech homepage.

By IMF Admin on August 21, 2011 5:24 AM | No Comments
You are now leaving the IMF website and are accessing the Ortho Biotech homepage.

Prolonged therapy improves quality of response, and CR associated with superior outcomes, with VMP

By IMF Admin on August 21, 2011 5:23 AM | No Comments
Prolonged therapy improves quality of response, and CR associated with superior outcomes, with VMP

Myeloma Quilt of Courage #5 - In Memory of Christal Mann Albert

By IMF Admin on August 21, 2011 5:09 AM | No Comments
Myeloma Quilt of Courage #5 - In Memory of Christal Mann Albert

Sydney 2005: Combination of Tipifarnib & Bortezomib Results in Synergistic MM Cell death...

By IMF Admin on August 21, 2011 5:08 AM | No Comments
Sydney 2005: Combination of Tipifarnib & Bortezomib Results in Synergistic MM Cell death...

Hand Printed Christmas Cards

By IMF Admin on August 21, 2011 5:06 AM | No Comments
Hand Printed Christmas Cards

Myeloma Quilt of Courage #4 - Frankie Salgado

By IMF Admin on August 21, 2011 5:06 AM | No Comments
Myeloma Quilt of Courage #4 - Frankie Salgado

Forming A Myeloma Support Group

By IMF Admin on August 21, 2011 5:06 AM | No Comments
Forming A Myeloma Support Group

Therapies for Relapsed or Refractory Disease

By IMF Admin on August 21, 2011 5:05 AM | No Comments
Therapies for Relapsed or Refractory Disease

International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Raje - Osteonecrosis of the Jaw

By IMF Admin on August 21, 2011 5:03 AM | No Comments
International Myeloma Workshop 2011
PRACTICAL ASPECTS ON THE MANAGEMENT OF MYELOMA BONE DISEASE
Dr. Raje - Osteonecrosis of the Jaw

September 22, 2003 Myeloma Minute

By IMF Admin on August 21, 2011 4:57 AM | No Comments
September 22, 2003 Myeloma Minute

International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 2
Dr. Munshi - Consensus guidelines for diagnostic Criteria and Indication for treatment and retreatment in plasma cell disorders

By IMF Admin on August 21, 2011 4:57 AM | No Comments
International Myeloma Workshop 2011
CONSENSUS REPORT: Panel 2
Dr. Munshi - Consensus guidelines for diagnostic Criteria and Indication for treatment and retreatment in plasma cell disorders

ASCO 2009 - Niesvizky: PX-171-006: Phase Ib multicenter dose escalation study of carfilzomib (CFZ) plus lenalidomide (LEN) and low-dose dexamethasone (loDex) in relapsed and refractory multiple myeloma (MM): Preliminary results.

By IMF Admin on August 21, 2011 4:56 AM | No Comments
ASCO 2009 - Niesvizky: PX-171-006: Phase Ib multicenter dose escalation study of carfilzomib (CFZ) plus lenalidomide (LEN) and low-dose dexamethasone (loDex) in relapsed and refractory multiple myeloma (MM): Preliminary results.